PEDOMAN PELAYANAN HIV-AIDS
TIM HIV-AIDS RUMAH SAKIT CAHYA KAWALUYAN
DAFTAR ISI
KATA PENGANTAR .............................................................................................................2 .............................................................................................................2 BAB I
PENDAHULUAN...................................................................................................3 PENDAHULUAN ...................................................................................................3
BAB II
LATAR BELAKANG BELAKANG..............................................................................................5 ..............................................................................................5
BAB IiI TUJUAN TUJUAN..............................................................................................................6 ..............................................................................................................6 BAB IV
PENGERTIAN…………................... PENGERTIAN………….......... .................. .................. ................. ................. .................. ....................................7 ...........................7
BAB V
KEBIJAKAN........ KEBIJAKAN ................. .................. .................. .................. ................. ................. .................. .........................................13 ................................13
BAB VI
STRUKTUR ORGANISASI........ ORGANISASI................. .................. .................. .................. ...............................................14 ......................................14
BAB VII KEGIATAN KEGIATAN.......................................................................................................15 .......................................................................................................15 BAB VIII METODA ..................................... .................. ...................................... ..................................... ......................... .............. ............. ............ ........... ..... 1 BAB I!
PEN"ATATAN DAN PELAPORAN................. PELAPORAN.................................... .............................. ................. ............ ............ ............ ........1#
BAB !
MONITORING DAN EVALUASI.................. EVALUASI..................................... ................................... ...................... ............ ............ .......... .... 2$
BAB !I
PENUTUP......................................................................................................... PENUTUP ......................................................................................................... 21
KATA PENGANTAR
P%&i '() *+%,%- ,(i /()&(0,() ,/('( T%() +() (( E*( ,(-)( (0(* ,%(*(N+( (,( /'() Ti HIVAIDS 'i RS. "(+( K((%+() '(/(0 'i*%*%) ')() 8(i,. D(( -(),( 8-/-() (,0i9 '(( /--( /):(() '() /)()%()() /)+(,i0 HIVAIDS 'i I)')*i( (,( R%( S(,i0 "(+( K((%+() 8)0%, 0i ,%*%* HIVAIDS +() )()0i)+( 8-/-() '(( /(+()() -((0 &(() 8(i /-i,*(() '() /)()()() 'i* /(*i) HIVAIDS *-0( (,%,() ,-'i)(*i;,-&(*(( ')() -%( *(,i0 &&(-i) (i))+(. T)0%)+( (,() ('( /(*((()< ,)'(( '() ,,%-()() '(( /(+()() HIVAIDS )()0i)+(< ,(-)( i0% ,(i )(-(/,() *(-() '() /-8(i,()< *%8()() /i,i-()< (*%,() *-0( ,-i0i,() +() 8-*i9(0 8()%). A,i- ,(0( ,(i )(-(/,() *( /'() i)i '(/(0 8-()9((0 %)0%, ,(&%() RS. "(+( K((%+().
BAB I PENDAHULUAN
HIV;AIDS HIV;AIDS 0( )&('i /()'i /()'i +() ),((0i-,( ),((0i-,() ) (*+(-(,( (*+(-(,(00 '%)i(< '%)i(< ,(-)( ,(-)( 'i*(/i) 8% 'i0%,() 8(0 '() =(,*i) %)0%, /):(()< /)+(,i0 i)i &%( ii,i >6i)'56 /1-i5' ? '() 9(* (*i0(0i, @0()/( &(( +() -(0i9 /()&() '(( /-&(()() /)+(,i0)+(. H( 0-*8%0 )+8(8,() /( /-,8()())+( */-0i 9))( %)%) *. J%( ,(*%* HIV;AIDS '(-i 0(%) , 0(%) 'i *%-% 8(i() '%)i( 0-%* )i),(0 *,i/%) 8-8((i %/(+( /-=)0i9 0-%* 'i(,*()(,(). Ti'(, ('( )(-( +() 0i'(, 0-,)( '(/(, /)+(,i0 i)i. Hi)( *((0 i)i HIV (*i -%/(,() *(( *(0% (*(( ,*(0() (*+(-(,(0 %0(( 'i I)')*i(. S&(, /-0(( ,(i 'i0%,() @1#7 *(/(i ')() 0(%) 2$11< ,(*%* HIV T-i')0i9i,(*i 0-*8(- 'i 36 @73<# '(-i 4# ,(8%/(0);,0( 'i *%-% @33 /-=i)*i 'i I)')*i(. K(*%* AIDS 0-8()+(, 'i(/-,() DKI J(,(-0( 'i*%*% P(/%(. N(%) &%( ,%%(0i9 ,(*%* AIDS /- 1$$.$$$ /)'%'%,< 0-8()+(, 'i(/-,() /-=i)*i P(/%( 8(-% 'i*%*% DKI J(,(-0(. P-=()*i HIV;AIDS 'i I)')*i( *:(-( %% () (*i -)'(< 00(/i I)')*i( 0( 'i),() *8((i )(-( ')() 0i),(0 /i'i +() 0-,)*)0-(*i +(i0% ('()+( /-=()*i 8i '(-i 5 /('( *%8//%(*i 0-0)0% i*()+( /)&(&( *,* '() /)+((%)( NAPCA @N(-,0i,(< @N(-,0i,(< P*i,0-/i P*i,0-/i,( ,( '() (0 ('i,0i9 ('i,0i9 (i))+(. (i))+(. Ti),(0 /i'i /i'i i)i )%)&%,,( )%)&%,,() ) 0i),(0 /-i(,% 8-i*i, +() :%,%/ (,0i9 )%(-,() /)+(,i0 'i '(( *%(0% *%8 //%(*i 0-0)0%. 0-0)0%. S()&%0)+( S()&%0)+( /-&(()() /-&(()() /i'i /i'i (,() 'i0)0%,() 'i0)0%,() &%( '() *i9(0 %8%)() ()0(-( ,/, 8-i*i, 0i)i ')() //%(*i %%. B8-(/( 0(%) 0-(,i- /(,(i() NAPCA (%i &(-% *%)0i, %(i )&('i /( /)+8(8 0i8%)+( HIV;AIDS< /)%(-() *:(-( :/(0 0-&('i ,(-)( /(,(i() &(-% *%)0i, 8-*((. P(-( /)+((%)( NAPCA *%)0i, i)i '(/(0 /%( )%(-i /(*()() *,*%()+(. Di ,(() ,(()() () /)% /)%)( )( NAPCA NAPCA *%)0i, *%)0i,<< i)9,* i)9,*ii HIV 88-,i ,i*(*(- ()0(-( ()0(-( 5$#$. 5$#$. D)() D)() 'i,i 'i,i() () '(*( i)i (*(( i)9,*i HIV 0i'(, ()+( 8-,(i0() -(0 ')() %8%)() *,* +() 0i'(, (() 0(/i ((0 -(0 %8%)())+( ')() /)%)(() NAPCA *%)0i,. A/((i /)%)(() NAPCA NAPCA *%)0 *%)0i, i, 8i(* 8i(*() ()+( +( 'i( 'i(,% ,%,( ,() ) ') ')() () :(-( :(-( 0i'( 0i'(, , 0-8 0-8%, %,( ( *i *i) )( ( 0i'( 0i'(, , %'( %'( /-,i-(,() /)%)(() NAPCA *%)0i, 'i I)')*i(. M%(*)+( HIV;AIDS (,() )i8%,() '(/(, 8%-%, 0-('(/ /8()%)() )(*i)( *:(-( *:(-( ,*% ,*%-% -%(). (). Ti'(, Ti'(, ()+( ()+( 88-/) /)((-% % 0-(' 0-('(/ (/ 8i'() 8i'() ,*( ,*(0() 0() 00(/i 00(/i &%( &%( /)(-%i 8i'() **i( ,)i. A/((i /)+(,i0 i)i /(i) 8()+(, 0-&('i /('( ,/, %*i( /-'%,0i9. /-'%,0i9. O ,(-)( i0% %/(+( /):(() /):(() '() /)()%( /)()%()() )() HIV;AIDS /-% 0-%* 'i(,%,().
BAB II LATAR BELAKANG
B-'(*(-,() (/-() *i0%(*i /-,8()() HIV;AIDS 'i I)')*i( *(/(i ')() 8%() J%)i 2$1$< P-=i)*i J(( B(-(0 )/(0i /-i),(0 ,'%( ')() ,(*%* AIDS 0-8()+(,< *0( P-=i)*i DKI J(,(-0(. J%( ,%%(0i9 ,(*%* i)9,*i HIV;AIDS 0-*8%0 *8()+(, 5.536 ,(*%* ,(*%* +() +() 0-'i0-'i-ii '(-i '(-i 3.33 3.33 ,(*%* ,(*%* AIDS AIDS '() 2.14 ,(*%* ,(*%* i)9,* i)9,*ii HIV @*%8- @*%8- L(/-( L(/-() ) S%-=i()* S%-=i()* AIDS D/,* D/,* RI 0(%) 1#7 J%)i 2$1$. "(*1 -(01 ,%%(0i9 ,%%(0i9 HIV;AIDS 'i J(( B(-(0 *((0 i)i +(i0% +(i0% #.44 /- 1$$.$$$ 1$$.$$$ /)'%'%,< *(( ')() ')() :(*1 -(01 ,%%(0i9 )(*i)(. N(%) 'i,i() '(( ,%-%) (,0% 3 8%()< *&(, M(-0 2$1$ *(/(i ')() J%)i 2$1$ 0( 0-&('i /)(8(() ,(*%* AIDS 'i J(( B(-(0 *8()+(, 111. H( i)i 8-(-0i 'i/-,i-(,() 0( 0-0%(- *,i0(- 11.1$$ -() (i))+( +() *8(i() 8*(- 8% 0-'0,*i. Ji,( i(0 'i*0-i8%*i ,(*%* AIDS 'i *%-% K(8%/(0);K0( +() 8-('( 'i P-=i)*i J(( B(-(0 *(/(i ')() 3$ J%)i 2$1$< ,(*%* AIDS 0-,)*)0-(*i 'i K0( B()'%)< +(i0% *8()+ *8()+(, (, 1.35 1.35 ,(*%* ,(*%* (0(% (0(% *,i0( *,i0(-- 41<5< 41<5< 'i*%*% 'i*%*% K0( K0( B,(*i B,(*i *8()+ *8()+(, (, 516 ,(*%* ,(*%* @15<5 '() K0( B- *8()+(, 251 ,(*%* @7<5. S)0(-( i0% 8-'(*(-,() 0-()*i*i (0(% :(-( /)%(-())+(< &%( ,(*%* AIDS ,%%(0i9 'i J(( B(-(0 0-8()+(, (%i &(-% *%)0i,@71<6#< *'(),() /)%(-() *:(-( *,*%( *,i0(- 22<1#@*,*%( 2<12 '() 0-*,*%( 2$<$7. () /-i(0i),() ('(( 0-()*i*i '(-i i8% , ()(, +() *:(-( ,%%(0i9 ):(/(i 3<3 +() 8-(-0i *,i0(- 11$ ()(, )i'(/ AIDS. B-'(*(-,() ,/, %%-< /-*)0(* ,%%(0i9 AIDS 'i P-=i)*i J(( B(-(0 *(/(i ')() 3$ J%)i 2$1$< 0-%0(( 'i0%,() /('( ,/, %%- 2$ (/(i ')() 3# 0(%)< +(,)i *8*(- <63 ,/, %%- 2$2# 0(%) @57<5 '() 3$3# 0(%) @31<$5. Di0(8( ')() ,/, %%- 4$4# 0(%) +(,)i 4<22< *,i0(- #2<5 /)'-i0( AIDS 'i J(( B(-(0 0-) '(( %*i( /-'%,0i9. () /-% 'i/-(0i,() 'i*i)i ('(( 0( 0-&('i /)i) /)i),(0 ,(0() () ,(*%* ,(*%* AIDS AIDS /('( /('( , ,/, /, %%- 'i 8(( 8(( 14 0(%) 0(%) 'i()( 'i()( &%( &%( ,(*%* ,%%(0i9)+( 0( 8ii 3 ,/, %%-1 0(%) @$<2< 14 0(%) @2<15 '() 514 0(%) @1<$6. Ji,( i(0 i(0 '(0('(0( '(0('(0( 0-*8%0 0-*8%0 '() ')() ')() 8()'i) 8()'i),())+ ,())+( ( ')() '(0('(0( '(0('(0( )(*i)( '() '%)i(< i)9,*i HIV;AIDS 0( )&('i (*(( '(-%-(0 8(. I)9,*i )&((*:(-( :/(0 0()/( ))( 8(0(* )(-( '() )+-() *%( (/i*() /)'%'%, @/-i( '() ()i0( '(-i *%( ,/, %%-< *%( /-9*i< ,(+( (0(% i*,i).
BAB III TUJUAN
A. TUJUAN UMUM
S8((i /()'%() '(( /(,*()(() /(+()() /)()%()() HIV;AIDS 'i R%( S(,i0 "(+( K((%+() B. TUJU TUJUAN AN KHUS KHUSUS US
1. 2.
BAB IV PENGERTIAN Vi-%* HIV
Meni Meningk ngkat atkan kan kual kualit itas as pelaya pelayana nan n kes keseh ehat atan an kepada kepada pende penderi rita ta HIV/ HIV/AI AIDS DS Meni Meningk ngkat atkan kan fun fungs gsii Ruma Rumah h Sakit Sakit seb sebaga agaii ruu ruuka kan n bagi bagi pend pender erit itaa HIV/ HIV/AI AIDS DS
Vi-%* HIV -%/(,() -0-=i-%* +() 0-) =i-%* RNA +(i0% =i-%* +() )%) )%)(,( (,() ) RNA *8(( *8((ii ,% ,% /8( /8(( ( i)9- i)9-(*i (*i )0i )0i,. ,. S8(( S8((ii -0-= -0-=i-% i-%*< *< HIV i ii i,i ,i *i9( *i9(00
,(* ,(* ,(- ,(-)( )( i ii i,i ,i )i )i
-= -=-* -* 0-() 0-()*: *:-i -i/0 /0(* (*< < +(i0 +(i0% % )i )i
+() ()
%),i),() =i-%* )%8( i)9-(*i )0i,)+( +() 8-('( '(( 8)0%, RNA , '(( 8)0%, 8)0%, DNA +() +() ,%'i ,%'i() () 'ii)0 'ii)0-( -(*i, *i,() () , '(( '(( i)9-( i)9-(*i *i )0i )0i, , * i9* i9*i0 i0 +() +() 'i*-(). Si)( HIV '(/(0 ()9((0,() ,()i* * i9*i0 %)0%, ),/i 'i-i)+( )&('i =i-%* 8(-% +() ii,i :i-i:i-i HIV. Vi-%* i)i '(/(0 'i0%,() '() 'ii*(*i '(-i * i9*i0 T< i9*i0 B< * (,-9( @'i 0(, '() /(-% '() 8-8((i :(i-() 0%8%. A,() 00(/i *(/(i *((0 i)i ()+( '(-(< (i- ()i '() :(i-() =(i)( +() &(* 0-8%,0i 0 -8%,0i *8((i *%8- /)%(-(). Si*0 i%) ()%*i( *()(0 ,/,* '() ii,i ,(i0() +() -%i0 ()0(-( 8-8((i &(-i)() '() * '(( 0%8%. K-%*(,() /('( *(( *(0% ,/)) *i*0 i%) (,() /)(-%i *i*0 i%) *:(-( ,*%-%(). P('( AIDS< ,/)) +() 'i*-() ('(( i9* i9*i0 i0 T/ T/- +() +() ii ii,i ,i -*/0 -*/0- "D4 'i //-%, %,((( ((())+ ))+(. (. T-'(/ T-'(/(0 (0 8()+(, 8()+(, 9%)*i 9%)*i /)0i) i9*i0 T /- ()0(-( (i) )(*i,() (0 ,ii( +() 8-/-() *8((i /-()*() /-0%8%() '() /8)0%,() ** (i) '(( *i*0 i%) '() /8)0%,() ()0i8'i. O ,(-)( i0% /('( /(*i) AIDS 0-'(/(0 ,(i)()< 'i()0(-()+( /('( 9%)*i i9*i0 T< i9*i0 B< )*i0 '() (,-9(.
P-&(()() /)+(,i0 HIV P-&(()() ((i( i)9,*i HIV '(/(0 'i8(i '(( 0((/() 8-i,%0 1. I)9 I)9,* ,*ii =i-%* =i-%* @2 @23 3 i) i)% % 2. Si)'- Si)'- -0-= -0-=i-( i-( (,%0 (,%0 @23i @23i) )% % 3. G&(( G&(( )i )i() () *-, *-,)= )=-* -*ii 4. I)9,*i I)9,*i ,-)i, HIV (*i0( (*i0(0i, 0i, @-(0(-(0( @-(0(-(0( 0(%)< 0(%)< 'i )(-( 8-,8() 8-,8() 8i /)', /)', 5. AIDS;H AIDS;HIV IV *i0 *i0(0i (0i, , @-(0( @-(0(-(0 -(0( ( 13 0(%) 0(%) 6. K(0i()
K(*i9i,(*i Ki)i* T-'(/(0 8-8((i ,(*i9i,(*i ,i)i* HIV;AIDS< 'i()0(-()+( )%-%0 "D" '() HO ('(( *8((i()( 0(/(, /('( 0(8 8-i,%0.
T(8 1. K(*i9i,(*i Ki)i* HIV '() "D4 /(*i) -(&( '() '(*( )%-%0 "D" "D4
KATEGORI KLINIS
T0(
5$$; 2$$4## 2$$;
2# 152 14
A
B
"
@A*i0(0i,<
@Si0(0i,
@AIDS
I)9,*i A,%0 A1 A2 A3
B1 B2 B3
"1 "2 "3
K(0-i Ki)i* A i/%0i i)9,*i HIV 0()/( &(( @(*i0(0i,< i9(')/(0i )-(i*(0( +() )0(/ @P1-*i*01)0 ;PGL '() i)9,*i HIV (,%0 /-iP1-*i*01)0 G1)1-(7iD1' G1)1-(7iD1' L+./2('1)5/ L+./2('1)5/(02+ (02+ ')() /)+(,i0 /)+-0( (0(% ('()+( -i(+(0 i)9,*i HIV (,%0. K(0-i ,i)i* B 0-'i-i (0(* ,)'i*i ')() &(( @*i0(0i* /('( -(&( (0(% -() '(*( +() 0-i)9,*i HIV +() 0i'(, 0-(*%, '(( ,(0-i " '() )%i /(i) ,%-() *(0% '(-i 88-(/( ,-i0-i( 8-i,%0 K('(( K('(() ) +() +() 'i%8% 'i%8%), ),() () ')() ')() i)9,* i)9,*ii HIV (0(% (0(% ('( ('()+( )+( ,-%*( ,-%*(,( ,() ) ,,8( ,,8(() () +() +() M1'i(01' I..%)i0+ I..%)i0+ (0(% 'i/-( 'i/-()0( )0(-( -( * @"177 M1'i(01' (0(% ,)' ,)'i* i*ii +() +() 'i() 'i() (/ (/ ',0 ',0- 0( 0(
-%,() /)()()() ,i)i* (0(% 8%0%,() /)(0((,*()(() (,i8(0 ,/i,(*i i)9,*i HIV. ")0 8-i,%0 i)i ('(( 0-(*%, '(( ,(0-i 0-*8%0 (,() 00(/i 0i'(, 0-8(0(* /('( :)0 i)i *(&(.
A)i(0*i* 8(*i(-i
K()'i'i(*i* -9(-i)(
K()'i'i(*i* =%=9(i)(
Di*/(*i( - -(i
D( 3<5$" (0(% 'i(- 8i '(-i 1 8%()
O-( H(i-+ L%,/(,i(
H-/* C*0-
I'i/(0i: T-8:+0/)i( P%-/%-( @ITP
Li*0-i*i*
P)+(,i0 R('() P()%
N%-/(0i /-i9-
K(0-i ,i)i* " i/%0i &(( +() 'i0%,() /('( /(*i) AIDS i*()+(
K()'i'i(*i* 8-),i< 0-(,( '() /(-%
K()'i'i(*i* */(%*
K(),- - -(i i)=(*i9
"::i'i+:*i* )+8(- (0(% 'i /(-%.
K-i/0,*i* 'i %(- /(-%
R0i)i0i* =i-%* *i0(
E)*9(/(0i +() 8-%8%)() ')() HIV
H-/* *i/,* '() %,%* ,-)i* 8i '(-i *8%() (()+(
B-),i0i*< *9(i0i* (0(% /)%)i(
Hi*0/(**i* )+8(- (0(% 'i %(- /(-%
I**/-i(*i i)0*0i)( ,-)i* 8i *8%() (()+(
S(-,( ,(/*i
Li9( B%-,i00
Li9( i%)8(*0i,
Li9( /-i- 'i 0(,
M+:8(:0-i% A=i% "/ @MA" (0(% M. K()*(*ii 0-*8(- (0(% 'i %(- /(-%
M. T%8-:%*i* /(-% (0(% ,*0-( /(-%
P)%:+*0i* &i-=:ii P)%)i(
P)%)i( +() 8-%()
L%,)*9(/(0i M%0i9,( P--*i9
S/0i,i( S()( +() 8-%()
T,*/(**i* 'i 0(,
T(8 2. K(*i9i,(*i Ki)i* I)9,*i HIV /('( -() '(*( )%-%0 HO
STADIUM I
GAMBARAAN KLINIS A*i0(0i*
II
Li9(')/(0i )-(i*(0( B-(0 8('() )%-%) 1$ '(-i BB *%(
SKALA AKTIFITAS A*i0(0i,< (,0i9i0(* )-( Si0(0i,< (,0i9i0(* )-(
K(i)() ,%i0 '() %,*( +() -i)() */-0 */-0ii ''-(0 (0i0i i0i** *8-i *8-i,< ,< /-%-i /-%-i<< )i,i,*i*< %,%* -( +() -,%-)< :ii0i* ()%(-i*
H-/* *0- '(( 5 0(%) 0-(,i-
I)9 I)9,* ,*ii
*(% *(%-( -() )
)(9( )(9(**
8(i 8(i() ()
(0(* (0(*
8-%() 8-%() */-0i */-0i *i)%*i0i* *i)%*i0i* 8(,0-i(i 8(,0-i(i*< *< III
0)*ii0i*< 9(-i)i0i*< (0(% 0i0i* 'i( B-(0 8('() )%-%) 1$ '(-i BB
P('( %%)+( (<
*%(
(,0i9i0(* 'i 0/(0 0i'%-
Di(Di(-
,-) ,-)i* i*
+() +()
0i'( 0i'(, ,
'i, 'i,0( 0(% %ii
,%-() '(-i 5$
/)+8(8)+ /)+8(8)+( ( +() 8-()*%) 8-()*%) 8i 8i '(-i 1 8%()
D( D( //-*i* *i*0) 0) 0()/( 0()/( *8(8 *8(8 +() +() &(*
@i)0-i0)
(0(%
,)*0()
37<5$" +() 8-()*%) 8i '(-i 1 8%()
K()' K()'i' i'i( i(*i *i**
-9 -9((-i) i) ( (
/-*i /-*i*0 *0) )
@0-%*
O-( H(i-+ L%,/(,i(
TB /(-% '(( 1 0(%) 0-(,i-
I)9 I)9,* ,*ii
8(,0 8(,0-i( i(
P)% P)%)i( )i(<<
+() +()
/+ /+(< (<
8-( 8-(00
@Mi* @Mi*..
/+i /+i*i *i0i*< 0i*<
i)9,* i)9,*ii 0%() 0%() (0(% (0(% *)'i< *)'i< )i) )i)i0i i0i** (0(% 8(,0-ii(
S0(0 S0(0i0i i0i** %*-( %*-(0i9 0i9 ):-0i ):-0ii) i) (,%0< (,%0< i)i=i0i* (0(% /-i')0i0i*
A)i( @;'< )%0-/)i(@$<5 1$#; 1$#;L L
'() '()
(0(% (0(%
0- 0-8 8*i *i0 0/ /)i )i( (
,-)i* ,-)i* +() +() 0i'(, 0i'(, '(/(0 '(/(0 'i0-( 'i0-(), ),() () IV
*8(8)+( HIV (*0i) (*0i) *+)'- *+)'- */-0 */-0ii +() +()
P('( %%)+( *()(0
'i'9i)i*i,() "D"
(< (,0i9i0(* 'i 0/(0
P)%:+*0i* P)%)i(
P)%)i(
8(,0-i
0i'%- 8i '(-i 5$ 8-(0
+()
8-%()
I)9,*i
-/*
*i/,*
,-)i*
@-(8i(< )i0( (0(% ()-,0( 1 8%() (0(% =i*:-(
K()'i'i(*i* *9(%*;0-(,(;8-),%*;/(-%
T,*/(**i* 0(,;SSP
Di(Di(- ,-i/ ,-i/0* 0*/ /-i -i'i 'i* *i* i* 8i 8i '(-i '(-i 1 8%()
K-i/0,*i* ,*0-(/%)(
I)9,*i "+0( Vi-%*
H-/* *i/,* %,,%0() 18%()
P--**i=
M%0i9:(
L%:):/(/(0+
"-+/0*/-'i*i* ,-)i*
I**/-i(*i* ,-)i*
Mi,*i* 'i*i)(0(
S/0i,i( 8-%()
K(-*i)( *-=i,* i)=(*i9
S(-,( K(/*i
E)*9(/(0i HIV
N9-/ N9-/(0i (0i (0(% (0(% ,(-'i ,(-'ii i/( /(0i 0i 0-,( 0-,(i0 i0
HIV +() *i0(0i* HIV (*0i) *+)'- 8-(0 8('() 0%-%) 8i '(-i 1$ 'i0(8( 'i(- ,-)i, 8i '(-i 1 8%() (0(% '( 8i '(-i 1 8%() +() 0i'(, 'i*8(8,() /)+(,i0 (i) E)*9(/(0i HIV ()%() ,)i0i9 '() (0(% 'i*9%)*i 0-i, +() )()% (,0i9i0(* i'%/ *(-i(-i '() 8-0(8( 8%-%, '(( 88-(/( i)% (0(% 8%() +() 0i'(, 'i*-0(i /)+(,i0 /)+-0( (i) *(i) HIV.
U)0%, ,/-%() *%-=i()* /i'ii AIDS 'i I)')*i( 'i%)(,() '9i)i*i ,(*%* *8((i 8-i,%0 S-() '(*( @12 0(%) 'i()(/ AIDS (/(8i( )%)&%,,() 0* HIV /*i0i9 ')() *0-(0i /-i,*(() +() **%(i ')() *,%-(),%-())+( 'i'(/(0,() 2 &(( (+- +() 8-,(i0() '() 1 &(( i)-< '() &(( i)i 8%,() 'i*8(8,() ,('(() (i) +() 0i'(, 8-,(i0() ')() i)9,*i HIV. G&(( M(+-
B-(0 8('() )%-%) 8i '(-i 1$ '(( 1 8%()
Di(- ,-)i* +() 8-()*%) 8i '(-i 1 8%()
D( 8-,/()&()() 8i '(-i 18%()
P)%-%)() ,*('(-() '() ()%() )%-i*
D)*i(;HIV )*9(/(0i
G&(( Mi)-
B(0%, )0(/ 8i '(-i 1 8%()
D-(0i0i* )-(i*(0(
A'()+( -/* *0- %0i*)0( '() H-/* *0- 8-%() 8-%()
K()'i'i(*i* -9(-i)(
H-/* *i/,* ,-)i* /--*i9
Li9(')/(0i )-(i*(0(
I)9,*i &(%- 8-%() /('( ((0 ,(i) ()i0(
R0i)i0i* =i-%* *i0(
BAB V KEBIJAKAN
R%( S(,i0 "(+( K((%+() 8%,() -%/(,() -%( *(,i0 -%&%,() /)()%()() HIVAIDS +() 'i0%)&%, K)0-i() K*(0().
R%( S(,i0 "(+( K((%+() (,*()(,() /)()%()() HIVAIDS **%(i ')()
/'() -%&%,() ODHA.
R%( S(,i0 )i,%0i (),( /(,*()(() /(+()() HIVAIDS *8((i 8-i,%0 (. M)i),(0, M)i),(0,() () 9%)*i 9%)*i /(+()() /(+()() V"T V"T @V%)0(-+ @V%)0(-+ "%)* "%)*i) i) ()' ()' T*0i) T*0i) 8. M)i),(0, M)i),(0,() () 9%)*i /(+() /(+()() () PMT"T @P-=)0 @P-=)0i) i) M0M0- 0 "i' T-()*i** T-()*i**i) i) :. M)i),(0, M)i),(0,() () 9%)*i 9%)*i /(+()() /(+()() I)9,*i I)9,*i O/-0%)i O/-0%)i*0i, *0i, @IO '. M)i),(0, M)i),(0,() () 9%)*i /(+()() /(+()() /)%)&() /)%)&() +() i/%0i i/%0i /(+()() /(+()() ii< (8-(0 (8-(0-i% -i% '() -('ii *-0( /):(0(0();/(/-().
P-** /)+%*%)() -):()( R%( S(,i0 %)0%, (,*()(,() /)()%()() HIVAIDS i8(0,() /i/i)() R%( S(,i0. Di-,0%- )0(/,() ,*%-%() i),%/ /(+()() HIVAIDS +() 'i(,*()(,()< *0-(0i /(,*()(()< ,()i* )i0-i) '() =(%(*i *-0( *i*0 /(/-().
P)+%* P)+%*%)( %)() ) - -%( %(*i< *i< /)+' /)+'i(( i(() ) 9(*ii 9(*ii0(* 0(* '() '() '%,%) '%,%)() () /8i( /8i(+(( +(() ) %)0%, %)0%, /--( /--( /(+()() HIVAIDS 'i9(*ii0(*i '(( R):()( K-&( A)(-() R%( S(,i0 '() 'i-(i*(*i **%(i ,0)0%() +() 'i00(/,().
Di-,0%Di-,0%- 8)0%, 8)0%, Ti P)()%() P)()%()() () I)9,*i I)9,*i HIVAIDS HIVAIDS +() (,() (,*()(,() (,*()(,() /)-()i /)-()i*(*i( *(*i()< )< /8%(0() /8%(0() /'() /'() ,-&(< ,-&(< /--( /--( ,-&(< ,-&(< )i0-i) )i0-i) '() =(%(*i =(%(*i /(,*()(() /(+()() HIVAIDS 'i -%( *(,i0. K0%( Ti 8-0()%) &((8 ()*%) ,/('( Di-,0%-.
P(0i() 'i(,*()(,() %)0%, *0(9 -%( *(,i0 %)0%, % )0%, )i),(0,() /(+()() HIVAIDS.
R%( S(,i0 "(+( K((%+() -%&%, /(*i) HIVAIDS +() -%,() /)8(0() ART @A)0i-0-=i-( T-(/+
R%( R%( S(,i S(,i00 "(+ "(+( ( K(( K((% %+( +() ) -% -%&% &%, , /(*i /(*i) ) ODHA ODHA ') ')() () 9(,0 9(,0- -i*i -i*i, , IDU IDU , /(+()() ,*(0() +() 8i ('(i. S%( *i*0 -%&%,() /)()%()() HIV AIDS 'i(,*()(,() R%( S(,i0 **%(i ,0)0%() +() 8-(,%.
R%( S(,i0 (,*()(,() /(+()() V"T
BAB VI PENGORGANISASIAN
DIREKTUR Drg. A. Friedrich John
KETUA TIM HIV-AIDS Dr Hendra William Goey
SEKRETARIS Devi Dara AMd. Keb
Pelayanan VCT
Pelayanan PMTCT
Pelayanan Penunjang
Pencatatan dan Pela!"an
Konselor
Devi Dara AMd. Keb
homas Ag!s AMK.Ak
$ki Mar%an Arya"h AMd
Dr Hendra William G
Ria Hardiant AMd. Kep
Aga"ha #vik Handayani AMd
Wening Wicaksono
BAB VII KEGIATAN
I. P) P)-i -i( (() () /(* /(*i i) ) HIV; HIV;AI AIDS DS
(. Pi,i)i, P(*i) ')() HIV;AIDS +() '(0() ')();0()/( *%-(0 -%&%,() '(/(0 'i0-i( 'i *%( 8i'() /(+()() 'i,< **%(i ')() /)+(,i0 /-0%)i*0i, +() 'i'-i0()+( */-0i 8(i() /)+(,i0 '((< *(-(9< ,%i0 '() ,(i)< ,8i'()() '() (i)(i). A/(8i( /(*i) 'i)+(0(,() (-%* 'i-((0 i)(/< /(*i) (,() 'i-%&%, , -%( *(,i0 -%&%,(). 8. I)*0( I)*0((*i (*i G((0 G((0 D(D(-%-( %-(00 @IGD @IGD P(*i) ')() HIV;AIDS +() '(0() , 8(i() IGD 'i(+()i **%(i /-*'%- *0()'(+() 8-(,%. 8-(,%. Ji,( /(*i) (-%* 'i-((0 'i-((0 i)(/ '() ,)'i*i ,)'i*i /(*i) /(*i) %),i), %),i),() () %)0%, 'i-%&%,< /(*i) (,() 'i-%&%, , -%( *(,i0 -%&%,(). Ji,( /(*i) 0i'(, 0-()*/5-0(871 (0(% (0(% 0i'(, '(/(0 'i-%&%, (,( /(*i) (,() 'i-((0 **%(i ')() ,%() %0(( /(*i) 8-'(*(-,() *0()'(- /-((0() /(*i) HIV;AIDS 'i-%()(). :. K( K((- J)( J)(*( *( P)'-i0( '(0() *%'( '(( ,('(() )i)(. P)()()() &)(*( '(/(0 'ii(0 /('( ((() 31. II. Si,(/ '(*(- 0)(( ,*(0() 1. B-* B-*i, i,(/ (/ 0)( 0)() )<< (&( (&(-< -< 0i'( 0i'(, , 8- 8-8 8i i() () '() '() )( )(:% :% /('( /('( *i,( *i,(/ / ,( ,(*/ */(' ('(( (() ) %)i=-*( @%)i=-*( /-:(%0i). 2. M)%8%,() M)%8%,() ,/-:(+( ,/-:(+(() () '() '() /)( /)(-(() -(() /(*i). /(*i). 3. B-%*(( B-%*(( %)0%, /,( /,( 0-('(/ 0-('(/ /-(*(() /-(*(() /(*i) /(*i) +() +() (8i '() '() 0%)&%,,() 0%)&%,,() *i,(/ *i,(/ /(0i 4. M)8() M)8(),() ,() %8%)() %8%)() *(i) *(i) /-:(+( /-:(+( '() '() )(-(i )(-(i (, (, /(*i) /(*i) 5. M8-i,( M8-i,() ) ,*/(0() ,*/(0() ,/('( ,/('( /(*i) /(*i) %)0%, ),*/ ),*/-*i, -*i,() () /-(*(())+( /-(*(())+( 6. M) M)-0i 0i<<
(( ((ii
'() '()
i ii i, ,i
,0-( 0-(/ /ii()
'(( '((
8-i 8-i, ,()
(*%( *%() )
,/-((0() /(*i) HIV;AIDS 7. M):i/0(,( M):i/0(,() ) %8%)() *%/-0i9 *%/-0i9 '() '() i)'(-,() i)'(-,() /-i(,% /-i(,% +() 'i*,-i 'i*,-ii)(0i i)(0i9 9 . M8() M8()0% 0% ')() ')() ) )%i %i ,8%0 ,8%0%( %() ) '(*('(*(#. M8-i,( M8-i,() ) ,*/(0() ,*/(0() ,/('( ,/('( /(*i) /(*i) %)0%, (,%,() (,%,() ,i(0() ,i(0() +() +() 8-%8%)() 8-%8%)() ')() i();,/-:(+(())+(. i();,/-:(+(())+(.
III. H(, '() K(&i8() P(*i) P('( '(*(-)+( /(*i) HIV;AIDS /%)+(i (, '() ,(&i8() *(( ')() /(*i) (i) 'i -%( *(,i0 1. H(, P(*i)
(. P(*i P(*i) ) 8- 8-(, (, )' )'(/ (/(0 (0,( ,() ) /( /(+( +()( )() ) ,* ,*( (0( 0()< )< (( ((00 '(-%'(-%-(0 (0<< //-(* (*ii '() '() /-*(i)() 8. P(*i) P(*i) 8 8 )-i )-i( ( ,%)&%)( ,%)&%)() ) '() 'i0() 'i0()ii *(( *(( '(( '(( (*( (*( //-(( ((0() 0() ,:%(i /('( ,)'i*i i)9,*i%* 8-(0 :. A/(8i A/(8i( ( 'ii&i) 'ii&i),() ,() ',0',0- @0-%0 @0-%0(( (( /(*i) /(*i) i)9,* i)9,*i%* i%*; ;)% )%(-< (-< */-0i */-0i TB"< TB"< /(*i) /(*i) 8 )%)&%)i 9(*ii0(* +() ('( 'i -%( *(,i0 */-0i -%() TV< -&(< '. '. P(*i) P(*i) ')() ')() 'i(- 'i(- 8-(0 8-(0 *8(i, *8(i,)+( )+( 'ii*( 'ii*(*i,( *i,() ) . P(*i) P(*i) 88-(, (, )-i )-i( ( ')')2. K( K(&i &i8( 8() ) /(*i /(*i) ) (. P(*i) P(*i) )0((0i )0((0i /-(0%/-(0%-() () '() '() 0(0( 0-0i8 -%( *(,i0 8. P(*i) P(*i) 8-i,() 8-i,() i)9-(*i i)9-(*i ')() ')() &%&%- '() '() *),(/)+( *),(/)+( 0)0() 0)0() /)+(,i /)+(,i00 +() 'i'-i0( ,/('( ',0- +() -((0 :. P(*i) P(*i) (0%i (0%i *(( *(( i)*0-%, i)*0-%,*i *i ',0',0- '(( '(( -(),( -(),( /)8( /)8(0())+ 0())+( ( '. P(*i) P(*i) (0%i (( (( +() +() *%'( 'i*/(,(0i 'i*/(,(0i;/-& ;/-&()&i( ()&i() ) +() 0( 'i8%(0. 'i8%(0.
IV. K)*i) HIV;AIDS A. V%)0(-+ "%)*i) ()' T*0i) @V"T 1. P) P) -0i( -0i() ) V"T -%/(,() ,i(0() ,)*i) 8-*i9(0 8-*i9(0 *%,(-( '() -((*i( +() 'i(,%,() 'i(,%,() *8% '() **%'( 0* ()0i HIV 'i (8-(0-i%. S0i(/ /-i,*(() ()0i HIV (-%* 'i*-0(i i)9-' :)*)0 2. T%&%( &%() U U% (. M)+' M)+'i( i(,() ,() '%,% '%,%)( )() ) /*i, /*i,i i** 8. M): M):( ( /)%( /)%(-() -() HIV ')() ')()
M)+' M)+'i( i(,() ,() i)9-( i)9-(*i *i 0)0() 0)0() /-i /-i(,% (,% 88-i*i i*i, ,
M8 M8() ()0% 0% ) ) 8( 8() ),( ,() ) ,( ,(i i() () /-i8 /-i8(' ('ii +() +() 'i/ 'i/- -%, %,() () %)0%, %)0%, )' )'%, %,%) %) /-i(,% i'%/ *(0
:. M(*0i,( M(*0i,() ) /)8(0() /)8(0() +() +() 9,0i9 9,0i9 *'i)i *'i)i %),i) %),i) **%(i **%(i *0()'(*0()'(- HO 0-(*%, 0-(*%, (0-)(0i9 /:(() 8-8((i (*(( 3. K)* K)* i) i) P-( P-( T* T* (. T%&%()
M8%(0 ,i) (/% %0%*,() (/(,( 'i-i)+( /-% -i,*(,() *0(0%* HIV )+( (0(% 0i'(,< ')() *(( ,)*,%)*i)+( 8. I*i I*i ,) ,)* *i i) )
M0i M0i99 / / -i, i,*( *(() () *%,( *%,(- -( (
I)0 I)0-/ -/- -0( 0(*i *i (*i (*i 0* *
U&i *(-i) =* ,)9i-(*i
T()/( &(( =* &(( )+(0(
P(( P((() () 8(( 8(( i)9,* i)9,*ii HIV '() '(/( '(/(,)+ ,)+( ( 0i'(, 0i'(, '(/(0 '(/(0 *8% *8% )(%) )(%) ODHA '(/(0 00(/ /-'%,0i9
I)9,*i /-0%)i*0i, '(/(0 'i8(0i
E*0i 0i(*i (*i 0*
K*i(/() )0( *i)( /)-i(() (*i 0*
K(&i( -*i, +() 0i'(, 'i(-(/,() (0(* (*i 0*
P-i' &)'( @i)' /-i'
M8 M8%( %(00 -) -):( :()( )( (0(* (0(* (*i (*i 0* 0*
A/( +() (-%* 'i(,%,() &i,( (* /*i0i9 (0(% )(0i9
M/-,i-(,() '%,%)() '(-i -() ',(0;*,i0(- /(*i)
M8()%) /((() i'%/ *(0 '() )'-) /-i(,% *(0
M8 M8%( %(00 ,/% ,/%0%* 0%*() () (, (,*( *()( )()( )(,( ,() ) 0* 0*
4. K)*i) P(*:( T* (. T%&%() M8%(0 ,i) (/% )-i( (*i /-i,*(() *0(0%* HIV)+( '() )+*%(i,() 'i-i ')() ,)*,%)*i '() -i*i,)+(< *-0( 8%(0 /-%8(() /-i(,% )&('i /-i(,% *(0. 8. I*i K)*i)
M)i(i ,('(() /*i,**i( 0-,i)i< )'%,%) )0(*i)( ,i)
M)i(i /((() ,i)
M)'%,%) *i ,i) '() )'-) ,i) 8-8i:(-( 8i ()&%0
M()(&) /:(() (*(( (i (*((< /((i '() /((,() /('( ,i) '() 8()0%( *%*%) -):()( %)0%, /-%8(() , /-i(,% *(0
Bi( ('( (*(( /*i,i(0-i< -%&%, , /*i,i(0-
B. P-=i'- I)i0i(0' T*0i) ()' "%)*i) @PIT" 1. P)-0i() PIT" ('(( ,i(0() /-i,*(() 0* HIV '() ,)*i) +() 'i/-(,(-*(i;'i*(-(),() /0%(* 'i*. J('i /('( ,i(0() i)i /(*i) *%'( )0(%i '() )+0%&%i %)0%, 'i(,%,() 0* 0-('(/ 'i-i)+(. H()+( /('( PIT" 0i'(, 'i(,%,() ,)*i) /-( 0*0. 2. T%&%() U)0%, /-%(* &(),(%() '() 8i /-%'( (,** /(+()().
". K)*i) /):(() 1. T%&%() M8%(0 ,i) ((i /-%)+( )i)'(-i /-i(,% 8-i*i,. 2. I*i K)*i) P((() HIV;AIDS '() '(/(, 9i*i, *-0( /*i,**i( "(-( /)%(-() '() /):(())+( P((() /-i(,% i'%/ *(0 M)'-) /-%8(() /-i(,% , (-( i'%/ *(0
D. K)*i) K%(-( 1. T%&%() A(- /(*i) '() ,%(-()+( *(i) *(i) )'%,%) '(( )('(/i ,('(() ,('(() '() ,)'i*i /*i,i*< 9i*i, '() **i()+(. 2. I*i ,)*i) P((() HIV;AIDS '() '(/(, 9i*i, *-0( /*i,**i( "(-( /)%(-() '() 0i'(, )%(-,()< /):(() P((() /-i(,% i'%/ *(0 M)'-) /-%8(() /-i(,% , (-( i'%/ *(0
E. K)*i) 8-,()&%0() 1. T%&%() A(- ,i) 0-8()0% )('(/i ,('(() ,('(() '() ,)'i*i /*i,i* +() 0-88()i 0-88()i (*(( ()%() ,*(0() 9i*i, '() &i()+(. 2. I*i K)*i)
I')0i9i,(*i 8-8((i (*(( +() 'i(&%,() /(*i). P-i-i0(* /):(() (*(( R):()( , '/() +() -(*i)(< /-%8(() /-*/*i +() 8i /*i0i9 K/(0%() 8-8(0< :(-( /)%)(()< -*i*0)*i '() 9, *(/i) M8-i,() 8()0%() (,** 0-('(/ /):(/(i() 8(0 R):()( )i,( '() )'(/(0,() ,0%-%)() "(-( i'%/ *(0 0-(*%, ii '() (-((
F. K)*i) T-i)( S0(0 1. T%&%() A(- ,i) 0)() '() 8-*-( 'i-i '(( )('(/i )('(/i (-i(-i (,i- ,i'%/())+(. ,i'%/())+(. 2. I*i K)*i) P((() (,() (,)( i'%/ P((() (,() (,)( ,(0i() "i0(:i0( +() *%'( 0-:(/(i "i0(:i0( +() 8% 0-:(/(i K/('( *i(/( '() 8((i()( :i0(:i0( +() 8% 0-:(/(i 'i*(/(i,(). P(+()() ,-()i() **%(i ')() i();,/-:(+(() ,i).
G. K)*i) M(*(( P*i,i(0-i* 1. T%&%() A(- ,i) 0-8()0% '(( )('(/i ,('(() '() ,)'i*i /*i,i(0-i* /*i,i(0-i* +() ('(. 2. I*i K)*i) I')0i9i,(*i ()%() /*i,i(0-i* I')0i9i,(*i (*(( 0-(*%, ,i)i)() 8%)% 'i-i R%&%,() , /*i,i(0 P((() /-%)+( ,/(0%() 8-8(0
V. T(0((,*()( P):(() P):(() P)%(-() '(-i I8% , A)(, ; P-=)0i) M0- T "i' T-()*i**i) @PMT"T P):(() /)%(-() HIV '(-i i8% , ()(, 'i(,*()(,() (%i ,i(0() ,/-)*i9 +() i/%0i /(0 /i(- @4 /-)< +(i0% 1. P):(() /)%(-() HIV /('( /-/%() %*i( -/-'%,*i @154# 0(%)
2. P):(() ,(i() +() 0i'(, 'i-):()(,() /('( /-/%() HIV /*i0i9 3. P):(() /)%(-() HIV '(-i i8% (i , 8(+i +() 'i,()'%))+( 4. D%,%)() /*i,i*< **i(< '() /-((0() ,*(0() *()&%0)+( ,/('( i8% +() 0-i)9,*i HIV '() 8(+i *-0( ,%(-()+(
1. P):(() /)%(-() HIV< /('( /-/%() %*i( -/-'%,*i @154# 0(%) P):(() /)%(-() HIV /('( /-/%() %*i( -/-'%,*i 'i*8%0 &%( *8((i /):(() /-i- +() 8-0%&%() ):( /)%(-() HIV '(-i i8% , ()(, *:(-( 'i)i. D)() :(-( (. M(,%,( M(,%,() ) '%,(*i M)i)' M)i)'(-i (-i /-i(,% /-i(,% *,*%( *,*%( 8-i*i, 8-i*i, ')() ')() *0-(0i *0-(0i AB"D A @A8*0i)):< (-0i)+( A8*) *,* (0(% 0i'(, (,%,() %8%)() *,* 8(i -() +() +() 8% 8% )i,( )i,( Q B @B F(i09 F(i09% %<< (-0i)+ (-0i)+( ( B-*i, B-*i,(/ (/ *(i) *(i) *0i( *0i( ,/('( ,/('( *(0% *(0% /(*()() *,* @0i'(, 8-()0i()0i /(*()() Q " @")'< (-0i)+( "( /)%(-() HIV (%i %8%)() *,*%( ')() )%)(,() ,)' Q D @D-% N< (-0i)+( Di(-() )%)(,() )(-,8(. 8. M)&(*, M)&(*,() () ()9((0 ()9((0 )0(% )0(%ii *0(0%* *0(0%* (0(% 0* HIV HIV *'i)i *'i)i %),i) %),i) :. M)i),(0, M)i),(0,() () /)0(%( /)0(%() ) /0%(* ,*( ,*(0() 0() 0)0() 0)0() 0(0((,*( 0(0((,*()( )( ODHA /-/%() /-/%() '. M)i),(0, M)i),(0,() () ,0-i8(0( ,0-i8(0() ) (,0i9 ,%(-( ,%(-( '() ,%)i0(* ,%)i0(* %)0%, %)0%, )i),(0,() )i),(0,() /)0(%() ,/-)*i9 HIV '() IMS . M)&(*, M)&(*,() () 0)0() 0)0() :(-( /)%-()( /)%-()() ) -i*i, /)%(-( /)%(-() ) HIV '() IMS< 0-(*%, 0-(*%, (%i (%i /)%)(() ,)' '() ((0 *%)0i, *0-i 9.
L(+()() L(+()() V"T ')() ')() //-(0i, (0i,() () 3 " +(i0% +(i0% "%)* "%)*i)< i)< ")9i' ")9i')0i( )0i(i0+< i0+< '() i)9-' :)*)0. Ji,( *0(0%* HIV i8% *%'( 'i,0(%i<
HIV /*i0i9 (,%,() i)0-=)*i PPIA ,/-)*i9 ((- i8% 0i'(, )%(-,() HIV ,/('( 8(+i +() 'i,()'%))+(
HIV )(0i9 (,%,() ,)*i) 0)0() :(-( )&(( ((- 00(/ HIV )(0i9
2. P):(() ,(i() +() 0i'(, 'i-):()(,() /('( /-/%() HIV /*i0i9
(. P-/ P-/%() %() ')() ')() HIV +() +() 0i'(, 0i'(, i)i) (i (i '(/(0 '(/(0 )%)( )%)(,() ,() ,)0-(* ,)0-(*/* /*ii +() +() **%(i ')() ,)'i*i)+( '() 'i*-0(i /)%)(() ,)' %)0%, ):( /)%(-() HIV '() IMS. 8. P-/%() P-/%() ')() ')() HIV +() %0%*,() %0%*,() %)0%, %)0%, 0i'(, /%)+(i /%)+(i ()(, ()(, (i 'i*(-(), 'i*(-(),() () %)0%, )%)(,() ,)0-(*/*i ()0(/ '() 00(/ )%)(,() ,)'. :. M8 M8-ii,()
,)* )*i i) ) '() '()
9 9(* (*i iii0(*i 0(*i
/-/ -/%( %() )
') ')() () HIV
+() ()
i)i )i)
-):()(,() ,(i() 3. P):(() /)%(-() HIV '(-i i8% (i , 8(+i +() 'i,()'%))+( (. L(+()() L(+()() AN" AN" 0-/('% 0-/('% 0-(*%, 0-(*%, /)(( /)((-() -() '() '() 0* 0* HIV P(+( P(+()() )() 0* HIV -%/( %/(,() ,() %/(+( %/(+( 8%, 8%,( ( (,** (,** 8(i 8(i i8% (i (i %)0%, %)0%, )0(%i *0(0%* HIV< *i)( '(/(0 (,%,() %/(+( %)0%, ):( /)%(-() HIV , 8(+i)+(< 8(+i)+(<//- /)8(0() /)8(0() ARV *'i)i *'i)i %),i)< %),i)< '%,%)() '%,%)() /*i,i /*i,i*< *< i)9-(*i '() /)0(%() 0)0() HIVAIDS. 8. Di( Di() )*i *i** HIV HIV P-i,*(() 'i()*0i, i)9,*i HIV '(/(0 'i(,%,() *:(-( =i-i* @)'0,*i ()0i) DNA (0(% RNA '() *-i* @)'0,*i ()0i8'i HIV /('( */*i) '(-(. P-i P-i,*( ,*(() () 'i() 'i()*0i *0i, , i)9,* i)9,*ii HIV +() +() 'i(,% 'i(,%,() ,() 'i I)') I)')*i( *i( %%)+( %%)+( ('( ('(( ( /-i,*(() *-i* )%)(,() 0* :/(0 @R(/i' T*0 HIV (0(% ELISA. :. P8P8-i() i() 0-(/i 0-(/i ()0i- ()0i-0-= 0-=i-( i-( P8P8-i() i() ARV /('( /('( i8% (i (i ')() ')() HIV *(i) *(i) '(/(0 '(/(0 )%-( )%-()i )i -i*i, -i*i, /)%(-() HIV '(-i i8% , ()(,< ('(( %)0%, )/0i(,() ,)'i*i ,*(0() i8% ')() :(-( )%-%),() ,('(- HIV *-)'( %),i). '. P-* P-*( (i)( i)() ) +() +() (( (() ) Pii() /-*(i)() i/%0i /-*(i)() /- =(i)( '() /- (8'i)( @8'( **(- (0(% *,*i **(-(. D)() 0-(/i ARV +() *,%-())+( 'i%(i /('( i)% ,14 ,(i()< /-*(i)() /- =(i)( -%/(,() /-*(i)() +() ((). A/(8i( 0-*'i( 9(*ii0(* /-i,*(() =i-( ('< ')() =i-( (' 1.$$$ ,/i;L< /-*(i)() /- =(i)( (() %)0%, %)0 %, 'i(,%,(). P-*(i)() 8'( **(- ()+( 8 'i'(*(-,() (0(* i)'i,(*i 8*00-i, (0(% &i,( /8-i() ARV 8(-% 'i%(i /('( *((0 %*i( ,(i() 36 i)% (0(% 8i< *i)( 'i/-,i-(,() =i-( (' 1.$$$ ,/i;L. . T(0((,*( T(0((,*()( )( /8-i /8-i() () (,()() (,()() 8(i 8(+i '() ()(,
I8% ')() HIV +() *%'( '(( 0-(/i ARV ii,i ,('(- HIV *()(0 -)'(< *i) *i)( ( (( (() ) %)0%, %)0%, )+%* )+%*%i %i 8(+i)+ 8(+i)+(. (. D(( D(( P'( P'() ) HIV '() I)9()0 I)9()0 F F'i) 'i) @2$1$< -' H(0 O-()i(0i) @HO -,)'(*i,() /8-i() ASI ,*,%*i9 *(( 6 8%() %)0%, 8(+i (i- '(-i i8% +() HIV '() *%'( '(( 0-(/i ARV %)0%, ,()*%)() i'%/ ()(, @HIV9- ()' :i' *%-=i=(. E,*,%*i9 (-0i)+( ()+( 'i8-i,() ASI *(&(< 0i'(, 8 'i:(/%- ')() *%*% (i) @i' 9'i). 9'i). S0( 8(+i 8-%*i( 6 8%() /8-i() ASI '(/(0 'i0-%*,() i)( 8(+i 8-%*i( 12 8%()< 'i*-0(i ')() /8-i() (,()() /('(0. Bi( i8% 0i'(, '(/(0 8-i,() ASI ,*,%*i9< (,( ASI (-%* 'i)0i,() '() 'i()0i,() ')() *%*% 9-%( %)0%, )i)'(-i i' 9'i). S()(0 0i'(, 'i()&%-,() )+%*%i :(/%- @i' 9'i)< (-0i)+( 'i8-i,() ASI '() PASI 8-()0i(). P8-i() *%*% 9-%( +() 8(i 'i)'i) %*%* 8(+i -%/(,() 8)' 8)'( (
(*i) (*i)
'(/( '(/(00
)i )i8 8% %,( ,() )
/-% /-%8( 8(( () )
%, %,*( *(
'i)' 'i)'i) i)
%*%* %*%*<<
*i *i) )( (
/-%'( (*%,)+( HIV +() ('( 'i '(( ASI , /-'(-() '(-(. 9. M)% M)%)' )'( ( '() '() ) )(0 (0%%- , ,( (i i() () . P8-i() P8-i() /-9i(,*i /-9i(,*i** ARV '() '() ,0-i, ,0-i,*( *( /('( ()(, P8-i() /-9i(,*i* ARV 'i%(i (-i /-0(( *0( (i- *(( 6 i)%. O8(0 ARV +() 'i8-i,() ('(( i'=%'i) @ACT (0(% CDV 4 ;,BB 'i8-i,() 2 ,(i *(-i. S()&%0)+( ()(, '(/(0 'i8-i,() ,0-i,*( /-9i(,*i* %(i %*i( 6 i)% ')() '*i*46 ;,88< *(0% ,(i *(-i< *0i(/ (-i *(/(i %*i( 1 0(%) (0(% *(/(i 'i()*i* HIV 'i0(,,() . P-i P-i,*( ,*(() () 'i() 'i()*0i *0i, , HIV /('( /('( ()(,. ()(,. A)0i8'i HIV '(-i i8% '(/(0 8-/i)'( , 8(+i (%i /(*)0( *(( ,(i() 8-('( 8('( /('( /('( '(-( '(-( 8(+i;( 8(+i;()(, )(, i)( i)( %*i( %*i( 1 8%(). 8%(). P))0 P))0%() %() *0(0%* *0(0%* HIV /('( /('( 8(+i;()(, @%*i(1 8%() '(-i i8% HIV 0i'(, '(/(0 'i(,%,() ')() :(-( /-i,*(() 'i()*i* HIV @0* ()0i8'i 8i(*(. P-i,*(() *-i* ()0iHIV '() /-i,*(() =i-i* HIV RNA @P"R 'i(,%,() *0( %*i( 1 8%() (0(% '(/(0 'i(,%,() 8i (( /('( %*i( #12 8%()< ')() :(0(0() 8i( (*i)+( /*i0i9< (,( (-%* 'i%() *0( %*i( 1 8%(). P-i,*(() =i-i*< */-0i HIV DNA @P"R< *((0 i)i *%'( ('( 'i I)')*i( '() '(/(0 'i%)(,() %)0%, )(,,() 'i()*i* HIV /('( ()(, %*i( 'i 8(( 1
8%(). P-i,*(() 0-*8%0 (-%* 'i(,%,() i)i( 2 ,(i '() '(/(0 'i%(i ,0i,( 8(+i 8-%*i( 46 i)% '() /-% 'i%() 4 i)% ,%'i()
4. D%,%)() /*i,i*< **i(< '() /-((0() ,*(0() *()&%0)+( ,/('( i8% +() 0-i)9,*i HIV '() 8(+i *-0( ,%(-()+(. U/(+ U/(+( ( /): /):( (( () ) /)% /)%((-() () HIV HIV '(-i '(-i i8% i8% , ()(, ()(, 0i'( 0i'(, , 8- 8-) )0i 0i *0 *0( ( i8% i8% (i-,(). I8% (,() i'%/ ')() HIV 'i 0%8%)+(. I( 8%0%,() '%,%)() /*i,i*< **i( '() /-((0() */()&() (,0%. H( i)i 0-%0(( ,(-)( *i i8% (,() )('(/i (*(( *0i( '() 'i*,-ii)(*i (*+(-(,(0 0-('(/ ODHA. F(,0- ,-((*i(() *0(0%* HIV i8% *()(0 /)0i) 'i&((. D%,%)() &%( (-%* 'i8-i,() ,/('( ()(, '() ,%(-()+(. B8-(/( ( +() %),i) 'i8%0%,() i8% ')() HIV ()0(-( (i) Q P)8(0() ARV &(),( /()&() Q P)8(0() &(( /)+(,i0)+( Q P-i,*(() ,)'i*i ,*(0() '() /()0(%() 0-(/i ARV @0-(*%, "D4 '() =i-( (' Q K)*i) '() '%,%)() ,)0-(*/*i '() /)(0%-() ,(i() Q I)9-(*i '() '%,(*i /8-i() (,()() 8(+i Q P):(() '() /)8(0() i)9,*i /-0%)i*0i, %)0%, 'i-i *)'i-i '() 8(+i)+(. Q P)+%%() ,/('( ()0( ,%(-( 0)0() :(-( /)%(-() HIV '() /):(())+( Q L(+()() ,i)i, '() -%( *(,i0 +() 8-*((8(0 Q K%)&%)() , -%( @ =i*i0 Q D%,%)() 0()0() **(( HIV /*i0i9< 0-8i **(( i8% ')() HIV Q A'()+( /)'(/i) *((0 *'() 'i-((0 Q D%,%)() '(-i /(*()() Q D%,%)() ,i(0() /)i),(0() ,)i ,%(-( Q D%,%)() /-((0() '() /)'i'i,() 8(i ()(,
VI. P-((0() K/-)*i9 B-,()&%0() B-,()&%0() 1. P-i)*i/ D(*(- (*%() K/-((0() (. P-((0() '() /):(() +() 0-/('% ')() 8-i,() (+()() /-((0() *:(-( ),(/ '() )+%-% 8. P-((0() +() 0i'(, 'i*,-ii)(0i9 '() )(,ii :. M)&(( ,-((*i(() '() )-(0i (, (*(*i ()%*i( '. A*%() ,/-((0() %)0%, -i)(),() &(( /)+(,i0 0-,(i0 HIV *-0( /):(()
0-&('i)+( i)9,*i )*,i( . S:(-( /(0i )')(-,() ,%() ODHA O DHA '() ,%(-()+(< *-0( 8-'(+(,() -,( ((- '(/(0 8%(0 -):()( , '/() 9. M)+'i(,() (,** '%,%)() 8(i /-((0() 'i -%( . M8ii*(*i *%8- '(+( 'i (*+(-(,(0 %)0%, /-((0() ),(/ '() 9i*i) . D%,%)() 8-%/( /)'i'i,() '() /(0i() *-0( *%/-=i*i 8(i /8-i (+()()
2. K(*/('(() U)i=-*( P-i)*i/ P-i)*i/ '(-i ,(*/('(() ,(*/('(() %)i=-*( %)i=-*( ('(( ('(( 8(( '(-( '() *%( &)i* :(i-() 0%8%< *,-0< ,*,-0(< ,%i0 +() 0i'(, %0% '() *(/%0 )'i- /)'-i0( 'i()(/ *8((i *%8/0)*i( %)0%, /)%(-() i)9,*i 0-(*%, HIV. A*%() ,/-((0() 8(i ODHA *(( *(&( ')() (*%() ,/-((0() 8(i /(*i) ')() /)+(,i0 (i). S%( /-i)*i/ (*%() ,/-((0() (-%* 'i&((),() *:(-( 8-0()%)&((8< 0-(*%, /)-(/() ,(*/('(() %)i=-*( *0()'(-. 3. P-(0%-() P,, P0%(* (. P0%(* /-((0() +() (i< i -i*, i)9:0i) '() /%)+(i %,(;'-(0i0i* 0i'(, 'i/-8,() -((0 /(*i) HIV;AIDS. 8. "%:i 0()() *8% '() **%'( -((0 /(*i) *,(i/%) *%'( )%)(,() *(-%) 0()(). :. M() 0% -((*i( &(8(0() 4. R%() P-((0() P('( /-i)*i/)+( /(*i) HIV;AIDS '(/(0 'i-((0 'i -%() i)9,*i 8i(*( @0()/( i*(*i. P(*i) 'ii*(*i ')() /-0i8()() (. Mi)'%)i /(*i) HIV;AIDS '(-i i)9,*i (i))+( 8. P(*i) ')() i)9,*i /-0%)i*0i, 8-(0 :. P(*i) '(( ,('(() 0-i)( '. P(*i) ')() ()i9*0(*i )%-i* @i*. ('%< i*( 5. U*(( P):(() P)%(-() (. "%:i 0()() *8% '() **%'( (*% -((0 8. S(-%) 0()() @()'*:) '() *:-0 *: -0 ,%*%* 'i%)(,() /('( *0i(/ (,%,() 0i)'(,() )) 8%() (i- 8*(-< 8%() (i- ,:i '() () ((0((0 +() 0-,)0(i)(*i.
:. G%)(,() (*,- '() ,(:((0( /i)'%) 8i( (,%,() /-*'%- i)=(*i9. '. J(-% *%)0i,;8)'( 0(&( J(-% *%)0i, '() i)*0-%) 0(&( (-%* 'i%)(,() (0i(0i *%/(+( *%/(+( /0%(* 0i'(, 0-0%*%,;0-%,(. J(-% *%)0i, 'i0%0%/,()< (*%,,() , '(( :)0(i)-;,() :)0(i)-;,() 8,(*< 8,(*< '() 'i8-i (8 (8 >SIDA? ')() )%)(,() */i' (-)( -(< (% 'i,i-i 'i,i-i , 0/(0 /8(,(-();i):i)-(0-. . I)*0-%) +() 0( 'i%)(,()< 'i-)'( '(( (i- /()(* 'i0(8( '0-) *8()+(, 1 *)', (,() '(( 1 i0- (i-< (0(% (-%0() ,-i) $<5 *(( 3$ )i0 ,%'i() 'i8i(*< 'i(*%,,() , '(( '(( ,()0) /(*0i, 8-(-)( -( (% 'i,i-i 'i,i-i , :)0-( *%//+ %)0%, 'i*0-i,() 9. R*%*i0(*i /-)(9(*() U)0%, )i)'(-i ,%),i)() /(/(-() /(/(-() HIV *8(i,)+( 0i'(, 'i%)(,() 'i%)(,() ((0 -*%*i0(*i. Bi( 0-/(,*( 'i%)(,()< ((0((0 0-*8%0 (-%* 'i:%:i 8-*i '() 'i'i*i)9,*i *0( 'i%)(,(). . U-i)( '() /i*/0 K0-() 'i8%() 'i8%() , , 0/(0 0/(0 /8%()()< /8%()()< %-i)( %-i)( '() '() /i*/0 'i8i(* ')() (i(i- /()(*< ,%'i() 'i-)'( '(( (i- /()()* 1 i0- 'i0(8( 1 *)', (,() '0-) *(( 3$ )i0 'i8i(* (% 'i,-i),(). . S(/( Di(*%,,() '(( ,()0) /(*0i, 08( 8-(-)( -(< 0%0%/ -(/(0. B-i (8 >SIDA? ')() )%)(,() */i' -( (% 'i,i-i , 0/(0 /8(,(-();i):i)-(0-. i. A(0 0)%) S0( 'i/(,(i 'i/(,(i 'i(*%,,() '(( ,()0) /(*0i, -(),(/ '%(. B-i (8 (8 >SIDA? ')() )%)(,() */i' -( ,%'i() 'i,i-i , 0/(0 /):%:i(). A(0 0)%) 'i-)'( '(( ,-i) $<5 *(( 1$ )i0< ,%'i() 'i:%:i ')() (i- /()(* '() '0-). P('( (,0% )()()i 8(() 0)%) +() ,0-< /0%(* (-%* (,(i *(-%) 0()() '() 8(&% /i)'%). &. A(0 /:( 8( S0( 'i%)(,()< 'i%)(,()< -)'( '(( (i(i- /()(* 1 i0- '() (-%0() ,-i) $<5 *(( 1$ )i0< 'i8i(* (% 'i,-i),() ,. S/*i)
H(-%* (0i(0i /('( (,0% (,0% /)(8i() */*i). G%)(,() *(-%) 0()() '() 8(&% /i)'%). B-i (8 >SIDA? ')() )%)(,() */i' -(< (*%,,() '(( 0(8%) (% 'i0%0%/. U*((,() 0i'(, )0-i 8(i() %(- 0/(0 */*i). i. A(0((0 )) 0( S0( 'i%)(,()< -)'( ')() ,-i) ,-i) $<5 *((1$ )i0. . K((- ()'i '() ,*0 Si-( ')() Ai- ,%'i ,%'i() () ') ')() () ( (ii- /()( /()(*; *;)' )'i'i i'i T-(,i-< T-(,i-< 8-*i,() 8-*i,() ')() ')() )%)( )%)(,() ,() :(i-() :(i-() ,-i) ,-i) $<$5
VII. S0()'(- A*%() K/-((0() ODHA D(*( (. D9i)i*i ,(*%* '(*( S-() '(*( @120(%) 'i()(/ AIDS (/(8i( )%)&%,,() 0* HIV ')() *0-(0i /-i,*(() +() **%(i ')() *,%-(),%-())+( 'i'(/(0,() 2 &(( (+- +() 8-,(i0() '() 1 &(( i)-< '() &(( i)i 8%,() 'i*8(8,() ,('(() (i) +() 0i'(, 8-,(i0() ')() i)9,*i HIV. 8. "(* *%8%)() ')() ('()+( ():(() ,(0i()+() 'i0()'(i ')() (/() (-(< /%0%* (*( '() )% 0(,%0. I)0-=)*i ,/-((() "i/0(,() %8%)() *(i) /-:(+( ()0(-( /-((0 ')() /(*i)< i*()+( ')() /-,)(,() 'i-i /('( /(*i). L(,%,() ,)0(, **-i) %),i) ')() /(*i) */-0i ')() *)0%()< (&(, 8i:(-(< 8-i ,*/(0() ,/('( /(*i) %)0%, ),*/-*i,() /-(*(())+( *i)( /(*i) 0i'(, -(*( *)'i-i (0(%/%) -(*( 'i0(,. J(*,() /)+8(8 '() /-** &(())+( /)+(,i0. B(0(*i /)%)()() 8(-(, *:-0;(*,- %)0%, )i)'(-i /-(*(() /(*i) '(-i -(*( 'i0(,. O8*-=(*i ('()+( 0()'(0()'( )(-i, 'i-i (0(% ,i)i)() %)0%, 8%)% 'i-i. I&i),() /(*i) %)0%, (-( '() &(*,() /-(*(() +() )-( ((- /(*i) '(/(0 ))0- /-(*(())+( '() )-i( ,('(().
B-i '%,%)() (%i 8i8i)() ,-()i() %)0%, )%-()i ,:(*(). R%&%, , /*i,i(0-< /*i,< /8i8i) -()i 8i( 'i/-%,().
:. P0)*i( i)9,*i *%8%)() ')() '(+( 0(() 0%8% +() )%-%)< 'i0()'(i ')() %,/)i(< *%898-i*< ()%() i)0-i0(* ,%i0. I)0-=)*i ,/-((0() "%:i 0()() *8% '() *0( ,)0(, ')() /(*i) %)0%, )%-()i -i*i, ,)0(i)(*i *i(). S'i(,() i),%)() +() 8-*i< =)0i(*i +() 8(i,< (-() /0%(*;/)%)&%) +() *'() )((i i)9,*i )('(,() ,)0(, 9i*i, ')() /(*i). L(,%,() i*(*i 8i( %,/)i( 8-(0 @-()%*i0 5$$ '() &(*,() ((*() 'ii*(*i. A)&%-,() /(*i) %)0%, 00(/ )&(( ,8-*i() ,%i0< %%0 '() 8*-=(*i ,('(() ,%i0 '() %%0 '(-i ('()+( ,()'i'(. M)i0- 0()'(0()'( =i0(. O8*-=(*i *%(-( )(9(* '(-i ('()+( i) '() -):i M)i0- ('()+( -(*( 0-8(,(-< '+*/(i(< -0-*0-)( /(i). G%)(,() *(-%) 0()() '() *:-0 *(( ,)0(, ()*%) ')() *,-*i;,*,-*i 0%8% /(*i) *((0 -((0 %,(. G%)(,( 'i*/*(8 *+-i) '() *0( )+%)0i, &(-% 'i0%0%/< ,%'i() ()*%) (*%,,() , '(( ,)0(i)- +() 0i'(, 08%* &(-%. B-i (8 >SIDA? ')() */i' -(. G%)(,() (8 ,%*%* /('( 0/(0 /)+i/()() /-i,*(() '(-( (0(% ,0-(). M)i0- /-i,*(() (8-(0-i% */-0i %,*i0< ,('(- H8< &%( i9*i0< &%( 0-8*i0 '() (/%* '(-(0/i. B-i ()0i8i0i,< ()0i &(%- **%(i ,('(() ,i)i*)+(. '. P( )(9(* 0i'(, 9,0i9 *%8%)() ')() 8-,%-())+( ,*/()*i /(-%< 8*0-%,*i 0-(:8-):i( +() 'i0()'(i ')() ('()+( **(, )(9(*< *i()*i*< -),i< i) '() ,-/i0(*i.
I)0-=)*i ,/-((0() O8*-=(*i /-%8(() ,*('(-() /(*i) O8*-=(*i /-)(9(*() 9-,%)*i< ,'((())+( A%*,%0(*i *%(-( )(9(* '(-i )%-%))+( (0(% 0i'(, ('()+( =)0i(*i< ('()+( ,-/i0(*i< i) '() -),i. E=(*i,() 8(i() ,/((< ()&%-,() )(9(* '(( %)0%, )/0i(,() 9%)*i /%)( %)0%, )%-()i 0-&('i)+( (*/i-(*i (0(% i)9,*i. L(,%,() *%:0i) 8i( ('( i)'i,(*i ')() /-(0i,() 0,)i, ,*0-i(). P0%(* )%)(,() (*,-< ,(:((0(< *(-%) 0()()< *:-0 %)0%, ):( 0-,)0(i)(*i ')() :(i-() 0%8% /(*i). A)&%-,() 8'-*0 M)i0- (* '(-( %)0%, )0(%i ,('(() ,*i)i*(*i '() *0(0%* =)0i(*i. L(,%,() 90 -(+ %() %)0%, )0(%i ('()+( i)9i0-(*i. B-i O2 %)0%, /-0((),() =)0i(*i +() 9,0i9. B-i ()0i8i0i, **%(i i)'i,(*i. . G()%() )%0-i*i 8-(0 8('() )%-%) *%8%)() ')() %(< 'i0()'(i ')() /)%-%)() 8-(0 8('() 1$< )(9*% (,() )%-%)< ,-( /-%0. I)0-=)*i ,/-((0() K(&i /)+8(8 )%-%))+( )(9*% (,()< */-0i ('()+( %,( /('( %%0. A%*,%0(*i 8i*i) %*%*. H+/-0ii0+ '(-i 0-(,0%* i)0*0i)( ('( %8%)())+( ')() %)0(< 'i(-. L(,%,() /-((0() %%0< i)'(-i /(,(i() (, %)0%, 8-i,() -(*( )+(()< )%-()i -(*( %(. B-i (,() TKTP< /-*i ,:i 0(/i *-i) '() 'i*(&i,() '(( 8)0%, )(-i, %)0%, )i),(0,() *-( (,(). A)&%-,() i*0i-((0 *8% (,() %)0%, i)i(,() -(*( ( ,(-)( /('( *((0 (,() )-i +() 'i%)(,() (,() )i),(0. P-0((),() i),%)() +() (() %)0%, )%-()i ,%),i)() i)&%-i. M)i0- (8-(0-i% *0(*i*< 0-8*i0 B-i 0-()*9%*i 8i( ('( i)'i,(*i Hi)'(-i /)%)(() /-'%, (*/i-i) %)0%, )%-()i (-(*i /(00.
VIII. A*%() K/-((0() A)(, ')() HIV;AIDS HIV;AIDS (. D9i)i*i ,(*%* ()(, A)(, %%- 8i '(-i 1 8%()< )%)&%,,() 0* HIV P*i0i9< '() *,%-(),%-())+( 'i'(/(0,() 2 &(( (+- '() 2 &(( i)- '() &(( 0-*8%0 8%,() 'i*8(8,() ,('(() (i) +() 0i'(, 8-,(i0() ')() i)9,*i HIV. A)(, %%- 1 8%() (0(% ,%-()< 'i0%,() 2 &(( (+- '() 2 &(( i)- ')() i8% +() HIV /*i0i9. G&(( i)i 8%,() 'i*8(8,() ,('(() (i) +() 0i'(, 8-,(i0() ')() i)9,*i HIV.
G&(( M(+- B-(0 8('() )%-%) (0(% (( 0%8% Di(- 0-%*)-%* (0(% 8-%() '(( (,0% 8i '(-i 1 8%() D( 0-%*)-%* (0(% 8-%() '(( (,0% 8i '(-i 1 8%() I)9,*i *(%-() /-)(9(*() 8(i() 8(( +() /(-( (0(% )0(/.
G&(( Mi)- Li9(')/(0i )-(i*(0( (0(% /(0*/)(i K()'i'i(*i* -( I)9,*i 8(,0-i '() (0(% =i-%* +() 8-%() B(0%, ,-)i* D-(0i0i* +() %(* E)*9(i0i*
8. A*%() ,/-((0() '(*(- /('( ()(, HIV /*i0i9 ')() i)9,*i /-0%)i*0i,. P('( '(*(-)+( (*%() ,/-((0() ()(, HIV /*i0i9 ')() i)9,*i /-0%)i*0i,< *(( *(&( ')() /(*i) ()(, (i))+( ')() 00(/ (,%,() /-i)*i/ ,(*/('(() %)i=-*(.
:. P8-i() ASI /('( 8(+i '(-i i8% HIV /*i0i9
M)+%*%i 8(+i)+( *:(-( ,*%*i9 *(( 6 8%() %)0%, *%( i8% +() 0i'(, 0-i)9,*i (0(% 0i'(, 'i,0(%i *0(0%* HIV)+(. I8% ')() HIV /*i0i9 'i()&%-,() %)0%, 0i'(, 8-i,() ASI '() *8(i,)+( 8-i,() *%*% 9-%( @PASI (0(% *%*% *(/i (0(% ,(8i) +() 'i):-,(). Bi( PASI 0i'(, %),i),() 'i*(-(),() /8-i() ASI ,*%*i9 *(( 6 8%() ,%'i() *-( 'i)0i,() %)0%, 'i()0i PASI. P8-i() ASI i)i ')() :(-( 'i/-(* '() 'i()(0,() '(%% /('( *%% 'i (0(* 66$" %)0%, 8%)% =i-%* HIV.
P-((0() P(i(0i9 (. P-((0() /(i(0i9 ('(( /-((0() %)0%, 8()0% -i)(),() /)'-i0(() 9i*i, (%/%) /*i,i* /('( /)'-i0( +() 0i'(, '(/(0 'i*8%,(). 8. B-i,() (*%() ,/-((0() 'i ,)+(()() /)'-i0( U)0%, )+-i ,-)i*< 8-i,() /)8(0() ')() '*i* -%(-< 8%,() *:(-( /-i'i,. M8()0% %)0%, -(,*(*i */-0i )(9(* /()&()< *,() 'i /%)%)< /i&i0() 8('(). U*((,() /)'-i0( 00(/ 8-*i '() ,-i) P)()0i() /*i*i *:(-( 0-(0%- %)0%, ,*(0() ,%i0 '() ):( ,)0-(,0%- '() ',%8i0%*. M8-i 0-()*i (,*i( ,/('( /)'-i0(< */-0i 0i'(, (% (,()< )(, (0(% i)0( 'i&)%,. M)-(0i ,8%0%() /)'-i0( %)0%, ()'i-i ')() /-8,() -,( )-&(,() (/( +() '(/(0 'i,-&(,() *)'i-i */-0i 8(i, 0%8%< 8-/i)'( /*i*i. :. P)-i(() 0-('(/ ,i()() '() /-%8(() M8-i '%,%)() ')() /-8,() /)'-i0( '() ,%(-()+( 8i:(-(,() /-(*(() -,(. M8(),i0,() (-( 'i-i ')() i(0 /('( ,8-(*i() i'%/)+( '() ))() (*( (%. M(,%i /-(*(() (-(< *'i (0(% *i '() -(,*i (i))+( /)'-i0(. '. P-*i(/() ,(0i() Bi( /(*i) 8-0()+( (0(% 'i0()+( (/( +() i)i) -,( ,0(%i< &(*,() ')() 8(i, 8(( /(*i) *%'( )',(0i (&( %)0%, )(8i *i,(/ 8-*-( 'i-i. S'(/(0 %),i) (,%,() **%(0% %)0%, -i)(),() -(*( )+-i (0(% &(( *8((i (,i8(0 /-** ,(0i().
P()i,() %(( **%(i ')() (((;,/-:(+(() /(*i) %)0%, )'(/(0 8,( -()i +() 'i/-%,() @%)0%, /(*i) K(0i, 'i%/(+(,() %)0%, '(/(0 )-i( *(,-() /-i)+(,(). B()0% /(*i) '() ,%(-()+( %)0%, -):()(,() (*i(0 0-(,i-)+( '() )(0%/(,(())+(. P('( (:(-( /(,(()< /)%-%*() &)(*(< (-%* **%(i ')() 8%'(+( *0/(0 0()/( )(8(i,() ,(i'( ,(*/('(() %)i=-*(.
P-*'%- D*i)9,*i '() S0-ii*(*i B()+(, /-*'%- (i) 0( 'i,)( *((0 i)i */-0i i*()+( -8%* '(( (i- )'i'i 0-)+(0( 9,0i9 8(i 8()+(, -()i*. Vi-%* AIDS (,() (0i 8i( ,)0(, *(( 3$ )i0 ')() (. A, 7$ 8. Li* 3 :. F-(i) 1 %)0%, &(-i)() *,-0( @9-(i) 1$ '. G%0(-('i' 2 . H2O2 3
T(8 5. "(-( )*0-i,() P-((0()
T,)i, A%0,(9 @%(/ ')() 0,()() 0i)i 2 (0 (0 O=) ,-i) M-8%* @(i- )'i'i M-)'( ')() ,-i) $<5
S% % 121 $" 17$ $" 6$1$$ $"
(,0% 2$ )i0 2 &( 2$3$ )i0 1$ )i0
P-*i(/() P(*i) P%() J(*,() ,/('( /(*i) '() ,%(-()+( 0)0() (. A0%-() A0%-() '() ,/(0%( ,/(0%() ) (,() (,() 8(0 ((((- /(*i) /(*i) i)% i)% 8(0 *:(-( *:(-( 0-(0%0-(0%- '() 0/(0 (,0% 8. Ti)'(, Ti)'(, ()&%0 ()&%0 ((((- /(*i) /(*i) 0(% ,(/() ,(/() (-%* (-%* ,)0- ,)0- , ',0',0:. P)0i) P)0i))+ )+( ( )%0-i* )%0-i*i i ((- /(*i) /(*i) (,() (,() (,()() (,()() 8-ii 8-ii %)0%, /-0( /-0(() (),() ,() '(+( 0(() 0%8% '. P-*) P-*)( ( ii) ii) ((- 'i(,%,( 'i(,%,() ) *:(-( *:(-( 0-(0%0-(0%- *0i(/ *0i(/ (-i %)0%, %)0%, ): ):( ( i)9,* i)9,*ii
,(-)( &(%. A,0i9i0(* A,0i9i0(* ((((- /(*i) (,%,() (,%,() (,0i=i0( (,0i=i0(** */-0i 8i(*(< 8i(*(< 00(/i &()() &()() (,%,() (,%,() *(/(i )i8%,() ,(() 8-8i(). 9.
L(-() L(-()() () )&('i )&('i ')')- '() /)%)(( /)%)(() ) &(-% *%)0i, *%)0i, *:(-( *:(-( 8-()0 8-()0i() i() (( ((-- 0i'(, 0i'(, 0-&('i /)%(-()
. "(-( (() (() %8%)() %8%)() *,*%( *,*%( ')() ')() )%)(, )%)(,() () ,)' ,)' *:(-( 8)(8)(- '() ')() ')() /(*()() *0i( . "("(-( ( /)%( /)%(-() -() ()+( ()+( (% (%ii ,)0(, ,)0(, ()*%) ()*%) ')() ')() '(-(< '(-(< *)< *)< *,-0 *,-0 :(i-() :(i-() =(i)(< ASI '() 9**.
P0%(* A8%()* (. Ti'(, ('( ('( /-*'%/-*'%- ,%*%*< ,%*%*< 00(/i 00(/ 00(/ /-(0 /-(0i,() i,() ,(*/( ,(*/('(() '(() %)i=-*( %)i=-*(. . 8. H( H()+ )+( (
/-% -%
> : :() ()ii:( :(
=)0i )0i( (0i 0i) )??
%)0% %)0%, ,
-*% -*%*i *i0( 0(*i *i
&()0 &()0%) %)
/(-% (-%
%)0%, )0%,
)i)'(-,() ,)0(, ()*%) %%0 , %%0.
P-((0() /(*i) HIV 'i -%( (. M):%:i 0()() *8% '() **%'( ,)0(, ()*%) ')() /(*i). 8. P(,(i( *(-%) 0()() 0()() 8i( ,)0(, ')() ')() '(-(< :(i-() 0%8% '() '() )()()i ((0((0 ((0((0 *-0( /(,(i() +() 0-,)0(i)(*i :(i-() 0%8%< '() /('( *((0 -((0 %,(. :. P(,(i()< */-i */-i '() ,(i) ,(i) (i))+( +() 0-,)0(i)(*i :(i-() 0%8% ((- 'i-)'( ')() :(i-() ,(/-i0 $<1 *(( 3$ )i0< ,%'i() 'i8i(* '() ,-i),() 'i 8(( /()(* (0((-i. '. K((- ()'i '() ,*0 ,*0 'i8-*i,() ')() (i(i- /()(* '() '0-) ,%'i() ,%'i() 'i(/ ')() :(i-() /%0i $<$5 'i ,((- ()'i (-%* ('( :(i-() : (i-() /%0i *0i(/ (-i. . B)'(8)'( 0(&( 0(&( */-0i /i*(% /i*(% :%,%- *0( 'i%)(,() 'i%)(,() 'i8%() /('( 0/(0 ,%*%* @i*()+( 80 *(i '(-i /(*0i, +() 0i'(, %'( 0-0%*%, (% 'i8(,(-. 9. B(-()8(-() 8,(* +() 0-,)0(i)(*i 0-,)0(i)(*i */-0i */-0i 0i**%< /8(%0 %,(< 'i(*%,,() 'i(*%,,() '(( ,()0) /(*0i, -(),(/ '%( (% 'i8(,(-. . B()0( '() ,(*%- (-%* (-%* 'i(/i*i /(*0i, +() 08( ((((- %'( 'i8-*i,() ')() (i(i/()(* '() '0-) ,%'i() 'i(/ ')() :(i-() /%0i $<$5 (% 'i&%- 'i 8(( *i)(- (0((-i. . A(0((0 (,() (,() '(/(0 'i8-*i,() ')() :(-( -)'( 'i (i(i- /()(* ')() '0-)
,%'i() 'i8i(* '() 'i,-i),().
P)()()() J)(*( P)()()() &)(*( /)'-i0( /)+(,i0 )%(- 'i(,*()(,() ')() *(% )-(/,() ,(*/('(() %)i=-*( 0()/( )(8(i,() 0-('i*i 8%'(+( '() ((( +() 'i()%0)+(. P0%(* (-%* '(/(0 )(*(0i ,%(-( &)(*( '() )(8i 0i)'(,() +() **%(i ((- /)()()() &)(*( 0i'(, )(8( -i*i, - i*i, /)%(-() /)+(,i0. (. Ti)'(, Ti)'(,() () 'i -%( -%() ) //-(( ((0() 0()
M):%:i M):%:i 0()() 0()() *8% *8% ( (,(i ,(i *(-%) *(-%) 0()() 0()()
M( M(,( ,(ii / /i) i)'%) '%) (& (&( ( '() '() &%8 &%8( (
L%-%*,( L%-%*,() ) 0%8% &)(* &)(*( ( '() 0(, 0(,,() ,() '(( '(( /*i* /*i*ii 0-)0( 0-)0() ) ')() ')() 0()() 0()() 'i*i*i 'i*i*i (0(% 0-i/(0 'i '('(.
T%0%/ T%0%/ ,/( ,/(, , (0( (0( '() (0(% (0(% 'i0%0% 'i0%0%/ / ')() ')() ,(/(* ,(/(* (0(% (0(% ,(*( ,(*( 8i0% 8i0% /%( /%( %%0< %%0< i'%) '() 0i)(.
B-i B-i ((* ((* ,/(( ,/(( ')( ')() ) ,(i) ,(i) ()'%, ()'%, %)0%, %)0%, )( )(/%) /%) 8i( ('( ('( -8 -8*() *() '(-( '(-( (0(% :(i-() 0%8% (i))+(.
T%0%/ T%0%/ ()% ()%** ')( ')() ) ,(*( ,(*( '() '() / /*0 *0- ,' ,'(/ (/ (i(i-..
L/(*,() L/(*,() *%( *%( ((0 ,*(0() ,*(0() '() 0(,, 0(,,() () ((0 ((0 8,(* 8,(* 0-*8%0 0-*8%0 '(( '(( ('( ('( +() (() **%(i ')() ,(i'( ,(*/('(() %)i=-*(.
T%0%/ T%0%/ *0 *0i( i(/ / %,( %,( ') ')( () ) /* /*0 0-- ,'( ,'(/ / (i-. (i-.
B-* B-*i i,( ,() ) 0%8% 0%8% &)( &)(*( *( '() '() 0%0% 0%0%/ / ') ')() () ,(i) (i) 8-* 8-*i i %)0% %)0%, , 'i*( 'i*(,* ,*i, i,() () ,%(-()+(.
B-i0(% B-i0(% /0%( /0%(** ,((,((- &)(*( &)(*( 8(( 8(( &)(*( &)(*( ('(( ('(( /)'-i0 /)'-i0( ( /)+(,i /)+(,i00 )%()%(-
T/(0 T/(0,() ,() &)( &)(*( *( 'i (0(* (0(* 8-() 8-(),(,(- '() '() ()0(()0(-,() ,() , , ,((,((- & &)(* )(*(. (.
"%:i "%:i 0() 0()() () *0 *0 ( ( / /(* (* *(*(-%) %) 0() 0()() ()..
8. Ti)' Ti)'(, (,() () 'i ,( ,(((- &)( &)(*( *(
L(,%,( L(,%,() ) /-*'%/-*'%- 8(,% 8(,% ,(*/ ,(*/('( ('(() () %)i=-* %)i=-*( ( +(i0% +(i0% :%:i 0()( 0()() ) *8% *8% (,(i (,(i *(-%) 0()()
J)(*(
'i()'i,()
/0%(*
,((-
&)(*(
+()
( ((i
:(-(
8-*i,();()'i,() &)(*( /)'-i0( /)+(,i0 )%(-.
"%:i "%:i 0()() 0()() ')( ')() ) *(8%) *(8%) *8% *8% (, (,(i (i *(-%) *(-%) 0()( 0()() ) '() **%'( **%'( /(* /(* *(-%) 0()().
P0% P0%( (** ( (,( ,(ii ((0 ((0 /i /i)' )'%) %)
S(-%) 0()() ,(-0 +() /()&() @*(/(i , *i,%
S8(i,)+( (,(i */(0% 80 *(/(i %0%0.
Pi)'%) (&( @(*,- '() ,(:((0(
J%8( (0(% :,< *8(i,)+( +() ,'(/ (i-
B%) B%),% ,%** &)( &)(*( *( ') ')() () ,(i) ,(i) ,(9( ,(9() ) (0(% (0(% /8%) /8%), ,%* %* ,%*% ,%*% &)( &)(*( *( (i) (i) **%(i **%(i ')() ((( '() ,/-:(+(())+(.
J)(*( J)(*( +() +() 0( 0( 'i8%) 'i8%),% ,%** 0i'(, 0i'(, 8 8 'i8% 'i8%,( ,( (i (i..
J)(*( J)(*( 0i'(, 0i'(, 8 8 'i8(* 'i8(* (0(% 'i*%)0i 'i*%)0i, , %)0%, /)( /)(0 0() () ,:%( ,:%(ii /0%( /0%(** ,%*%* +() 0( (i- '(( ( 0-*8%0
J)( J)(*( *( 0i'( 0i'(, , 8 8 'i0 'i0/ /*i *i.. D( D(( ( ( ( 0-0 0-0)0 )0% % 0/ 0/*i *i '(/( '(/(00 'i( 'i(,% ,%,( ,() ) *0 *0( ( )'(/(0 /-*0%&%() '(-i /i/i)() -%( *(,i0 '() 'i(,*()(,() /0%(* +() 0( (i- '(( ( 0-*8%0.
B8-( B8-(/( /( ( (i) (i) +() +() //-% % 'i/- 'i/-(0i (0i,() ,()
S-( ):%:i ,%i0 '() /-%,(() (i) ')() (i- )(i- 8i( 0-,)( '(-( (0(% :(i-() 0%8% (i)
S0i(/ /-%,(() +() 0-,)( /-:i,() (0(% 0%/(() '(-( '() (0(% :(i-() 0%8% (i) *-( 'i8-*i,() ')() (-%0() ,-i) $<5
S%( S%( //-(( ((0() 0() +() +() (,() (,() 'i%)( 'i%)(,() ,() ,8( ,8(ii (-%* (-%* 'i/-* 'i/-*** ')() ')() %-%0() ',)0(i)(*i< 'i*i)9,*i (0(% *0-ii*(*i
S(/( S(/( '() 8(() 8(() 0-,) 0-,)0( 0(i)( i)(*i *i (i))+ (i))+( ( 'i0/ 'i0/(0, (0,() () '(( '(( ,()0) ,()0) /(*0i, 8-(-)( -( '() 'i8-i (8 >SIDA?.
P8%()() P8%()() *(/( '() 8(() +() 0-:(0-:(- **%(i **%(i :(-( /)(() /)(() *(/( 'i*.
P)()()() 8i( 0-&('i /(&()() 'i R%( *(,i0 1. Ti)'(, Ti)'(,() () *0 *0( ( 0-& 0-&('i ('i /(& /(&()( ()() ) (. L%,( 0%*%,() 0%*%,() &(-% &(-% (0(% %,( %,( i-i* i-i* *-( 'i:%:i 'i:%:i *(8%) *(8%) '() (i(i- )(i)(i8. P-:i, P-:i,() () /('( %,*( %,*( i'%) i'%)<< %%0 %%0 (0(% ,%i0 ,%i0 *-( *-( 'i8i(* 'i8i(* ')() ')() %+%-() %+%-() (i-. :. M(0( 'ii-i 'ii-i(*i (*i ')() ')() (i- 8-*i< 8-*i< (-%0() (-%0() (-( (-( 9i*i 9i*ii* i* (0(% (0(% (i- *0-i *0-i '. J(-i +() +() 0-0%*%, 0-0%*%, 0i'(, 8 8 'ii*(/ 'ii*(/ ')() ')() %%0 */-0i */-0i ,8()+(, ,8()+(,() () 0i)'(,() 0i)'(,()
-9,* %)0%, )i*(/ '(-( 2. L(/ L(/-( -() ) P(& P(&() ()() () (. S0i S0i(/ (/ /(&( /(&()( )() ) (-%* (-%* 'i:( 'i:(0( 0(00 '() '() 'i( 'i(/ /-, -,() () ,/( ,/('( '( 0i 0i P): P): ( (() () '() '() P))'(i() I)9,*i @PPI R%( S(,i0 (0(% Ti K*((0() '() K*(0() K-&( @K3RS. 8. L(/-( L(/-() ) *()(0 *()(0 'i/-%, 'i/-%,() () %)0%, %)0%, /8/8-i() i() /-9i(, /-9i(,*i* *i* /(*:( /(&()() /(&()() '(( '(( (,0% 24 &(. :. M% M%( (ii /) /)8 8(0 (0() () *0 *0( ( 72 &( &( 0i'( 0i'(, , 'i() 'i()&% &%-, -,() () ,(- ,(-)( )( *( *(,i ,i) ) (( (( 0-0%)'( *(,i) ,:i (-0i /-9i(,*i* /(*:( /(&()(). 3. P-9 P-9i i(, (,*i *i** P(& P(&() ()() () (. M))0 M))0%,( %,() ) ,' ,' /(&( /(&()() )() HIV @KP @KP 8. M))0 M))0%,( %,() ) ,' ,' *0(0 *0(0%* %* HIV HIV @KS @KS :. M))0%,() M))0%,() /)8(0 /)8(0() () /-9i(,*i* /-9i(,*i* /(*:( /(*:( /(&()() /(&()() **%(i **%(i ,(0-i ,(0-i /(&()() /(&()() '() ,' *0(0%* HIV '(-i *%8-. '. M(,%,() M(,%,() 0* HIV HIV *-( *0( *0( 0-/(&()< 0-/(&()< 3 8%() '() 6 8%() 8%() *()&%0)+( *()&%0)+(..
P-*'%- P)()()() P('( Ti)'(,() K%*%* 1. T(0((,*()( 'i K((- Ti)'(,() B'( P('( /-i)*i/)+( 8i( ,(*/('(() %)i=-*( 0( 'i(,*()(,() ')() 8(i, (,( -i*i, /)%(-() *()(0 ,:i. (. S8% Ti)'(,() B'(
S'(/(0 %),i) )+'i(,() ((0((0 +() *,(i /(,(i @'i*/*(8. A(0((0 +() '(/(0 'i%)(,() ,8(i (-%* 'i*%:i((,().
M)+'i(,() ('( +() 0i'(, %'( 08%* '() 0( 'i8-i 'i*i)9,0() @,-i) $<5 %)0%, 8)'( 0(&( */-0i /i*(%< &(-%< '*0.
M)+'i(,() ('( /(*0i, 8-(-)( -( +() 'i8-i (8 >SIDA? %)0%, ,(i) ,(*( 8,(* +() 0-:(- :(i-() 0%8% /)'-i0(.
M)+' M)+'i(, i(,() () (( ((00 /i)' /i)'%) %) %)0%, %)0%, /-(0 /-(0-; -;i)* i)*0-% 0-%)0 )0(0 (0-;( -;(*i* *i*0) 0) 88-%/( %/( *(-%) *(-%) 0()()< (*,-< ,(:((0(< &%8( /(*0i,< 0/i 8'(< */(0% ,(-0.
M)+'i(, M)+'i(,() () ((0 /i)'%) /i)'%) 0%8% %)0%, /0%(* /0%(* /8-*i /8-*i */-0i */-0i *(-%) 0()() 0()() -%( 0()(< */(0% 80 ,(-0< &%8( /(*0i,< (*,-.
L(/i*i &( 8'( ')() /(*0i, 0-()*/(-().
8. P('( *((0 0i)'(,() 8'(
S%( S%( /0%( /0%(** +() +() (,% (,%,() ,() 0i)'(, 0i)'(,() () +() +() 88-%8 %8%) %)() () ')() ')() :(i-() :(i-() 0%8% 0%8% /)'-i0( (-%* (,(i *(-%) 0()().
P0%(* +() %),i) 0-,)( /-:i,() :(i-() 0%8% /)'-i0( (-%* (,(i *(-%) 0()()< ,(:((0( '() (*,- @/-(0-< (*i*0) /-(0-< i)*0-%)0(0-< '
U)0%, )i)'(-i %,( 0%*%, (,( 8i( i)*0-%)0(0- 8-i,() i)*0-%)0 0(&( ,/('( ,/('( /-(0 /-(0- ((-%* %* *:(-( *:(-( 0i'(, 0i'(, ()*%) ()*%) +(i0% +(i0% ')() ')() )% )%)(, )(,() () 0/(0 0/(0 ,%*%*. Bi0% /%( *8(i,)+(.
U)0%, )()0i*i/(*i -i*i, ,-%*(,() *(-%) 0()()< /-(0- )%)(,() '%( (/i* *(-%) *(-%) 0()() 0()() '() )( )()0i )0i *(-%) *(-%) 0()() 0()() 88-( 88-(/( /( ,(i ,(i 8i( 8i( 0i)'(, 0i)'(,() () 8'( 8'( 8-()*%) ((.
B-(0i(0i ,((% (*%,,() 0()() , '(-( 0i)'(,() 8'( +() *%,(- 'ii(0< %)0%, )i)'(-i %,( 0%*%, 8i( ('( 8)'( 0(&(.
"(i-() 0%8% +() ,(0 'i 8('() /)'-i0( (-%* 'i8-*i,() ((- 0i'(, ))(i -() (i).
Bi( 'i/-%,() 0i)'(,() -*%*i0(*i< %*((,() ((- 0i'(, (,%,() -*%*i0(*i *:(-( ()*%) %%0 , %%0.
:. S*%'( 0i)'(,() 8'(
A(0 +() *,(i /(,(i /(,(i *0( 'i'i*i)9,0() (-%* *-( 'i%*)(,(). 'i%*)(,().
A(0 +() (,() 'i/(,(i ,8(i 'i-)'( '(( (-%0() ,-i) $<5 *(( ,%-() '(-i 1$ )i0 *8% 'i8-*i,() '() ,%'i() 'i*%:i((,().
B(&% /-(*i +() 0-/-:i, 0-/-:i, :(i-() 0%8% 'i-)'( 'i-)'( ')() 'i*i)9,0 'i*i)9,0() () ,-i) ,-i) $<5 *(( 1$ )i0< ,%'i() 'i,i-i , 8(i() ,((- :%:i.
2. P-i,*(() L(8-(0-i% (. S0i(/ /-i,*(() ()0i HIV (-%* 'i*-0(i ,)*i) /-( 0* '() /(*:( 0*< *-0( i)9-' :)*)0. 8. P-*'%- /)(8i() '() /)i-i() *(/ '(-(
P0%(* )%)(,() *(-%) 0()() '() *:-0
P)(8i() '(-( ')() */%i0 'i*/*(8
D(-( +() *%'( 'i(8i 'i(*%,,() , '(( 0(8%);0(8%) *)0-i9%* +() *%'(
('( 0%0%/)+(.
P)i-i() '(-( (-%* )%)(,() 0(8%) +() 'i(*%,,() , '(( 0/(0 +() 0-0%0%/ '() 'i8-i (8 >SIDA? ')() )%)(,() */i' (-)( -(.
M&( +() 0-:(- */:i)< 'i8-*i,() ')() 'i*i)9,0() ,-i) $<5.
:. S0-(0i /-i,*(() (8-(0-i%
U)0%, /-i,*(() /-0(( 8i(*()+( 'i%)(,() -(/i' 0*0 %)0%, (,%,() %&i *(-i).
U)0%, U)0%, (*i (*i +() +() /*i0i /*i0i99 (,() (,() 'i/-i 'i/-i,*( ,*( %() %() ')() ')() )% )%)(, )(,() () 0'( 0'( +() +() 8-8'( '() (0(% )%)(,() /-/(-(*i ()0i) +() 8-8'( %)0%, i)i(,() ('()+( (*i /*i0i9 /(*% +(i0% ')() :(-( ELISA @E)+i),' i%)*-8)0 (**(+ (0(% /-i,*(() *&)i* +() /%)+(i */*i9i0(* 8i 0i)i '(-i -(/i' 0*0.
Bi( 0-*'i( 0* ,)9i-(*i (,( %)0%, /-i,*(() ,3 '(/(0 )%)(,() B @*0 @*0-) -) B0 B0.. P-i P-i,*( ,*(() () ()0i ()0i HIV 'i)+( 'i)+(0(, 0(,() () /*i0i /*i0i99 8i( 8i( 0( 0( 'i(,% 'i(,%,() ,() 3 /-i,*(() ')() 0' +() 8-8'(.
U)0%, 8(+i '(-i i8% ')() HIV /*i0i9< (,( (*i /*i0i9 /('( 8(+i %%- ,%-() '(-i 1 8%() ('( '%( ,%),i)() +(,)i 8(+i 8(( ()0i8'i HIV '(-i i8%)+( (0(% 8(+i 0-*8%0 0-i)9,*i HIV '() (,() 00(/ 8-i,() 0* /*i0i9.
U()i 0* *0i(/ 3 8%() *(/(i ()(, 8-%%- 1 8%().
3. F0 R)0) '() USG (. G%)(,() /(*0i, ,'(/ (i- %)0%, ((* 0/(0 0i'%- /(*i). 8. S0( 'i/(,(i 8-*i,() ')() ,-i) $<5
4. P)()()() /-*(i)() (. P(*i) ')() HIV;AIDS 8-(, )'(/(0,() )'(/(0,() /-0)() /-*(i)() */-0i /(*i) (i))+(. 8. P-*(i)() 00(/ 'i(,%,() 'i OK;VK **%(i i)'i,(*i. :. P0%(* +() )) /-*(i)() ))(,() *(-%) 0()()< *:-0< (*,-< ,(:((0( '() */(0% 80. '. Hi)'(-i /(-0%* (( '() 0i)'(,() i)=(*i9< ()i0i *8% /8%,(() ),(/< /i*i0i< ,*0-(,*i :%)(< '() ()(i*( (* '(-( 8(+i.
5. P-((0() Gii (. D(/(0,() -i(+(0 /)+(,i0 '(-i 0i(/0i(/ /(*i)< 0-(*%, (( ))(i 8(08(0()< /)+(,i0 +() 8(-% 'i'-i0()+(< /)+(,i0 8-%()< 8-(0 8('() +() )%-%) 0()/( 'i*)(&(< +/(')/(0+< *i %,*( (0(% i)9,*i (i). 8. "%:i 0()() *8% '() **%'( (,%,() /-i,*(() -(< %)(,() *(-%) 0()()< '() **(i,() /,-&(() /('( *(0% /(*i). U)0%, /(*i) 8(-% (-%* )%)(,() *(-%) 0()() 8(-%. :. G%)(,() (*,- '() ,(:((0( /i)'%) *(/(i , '(% 8i( 'i '(% (,() 0-&('i /-:i,() :(i-() 0%8%. '. Li)'%)i ((0((0 +() *%i0;0i'(, %),i) 'i'i*i)9,0() @*/-0i /() (/% !R(+ %)i0 ('*< %0(-)+( ')() /(*0i, ,'(/ (i-. . K%-()i *,:i %),i) (,() 0-&('i)+( 0 -&('i)+( /-:i,()< i*()+( ')() )%)(,() -%88'(< i */:0 =(:%(0i)< /*i*i /(*i) +() 0/(0. 9. P('( 88-(/( /-*'%- 0-0)0% -%,() i)&,*i ()*0*i (0(% 8(08(0() *:(8-%()%() '(-i *(0% *+-i)< (,( 8i 8i&(,*()( 8i( 0(,() &(-% 0()&() 0-*8%0 'i(0(* *8%( 0/(0 *0-i i*( /i(( i)&( *0-i< ', *0-i. S+-i) *0-i '() (-%0() +() 8(-%< 'i%)(,() %)0%, (*i)(*i) /(*i). . A(0((0 0)%) '() i)*0-%) +() 'i%)(,() (-%* ()*%) 'i*0-i,() *0i(/ (8i* 'i/(,(i ')() -)'( '(( (-%0() ,-i) $<5 *(( 1$ )i0. P0%(* +() 8-*i,())+( (-%* (,(i *(-%) 0()(). K%'i() ((0 0)%) 'i*-(,() %)0%, 'i:%:i 'i ,((- :%:i. . ,(-)( ,/ /)+'0 (i- '(/(0 )i*(/ 8(() i)9,*i ,8(i , ()'/i: '() *()< (,( (i- ,/ /)(() @::,=(=* (-%* 'i/(*() '(( ')0( %)i0 %)0%, )%-()i -i*i, /i)'(() '(-i 8(()8(() i)9,0i9. S8-(/( 8*(- ,%),i)() i)i 8% '(/(0 'i,0(%i< *8(8 i0% ('(( 8i&(,*()( %)0%, )&((),() (i- '(-i %)i0 *(( 2$3$ '0i, *0( **(i 'i%)(,() %)0%, *(0% /(*i). P-** i)i 'i%+() %)0%, 88-(/( )i0 /('( *((0 ,i)i, 'i%(i %)0%, )%(-,() ,%/%() 8(,0-i *(( *8%)+(.
6. P-((0() M(0( (. "%:i 0()() *8% '() **%'( (,%,() /-i,*(() (0( (0(% /-*'%- (i) +() 0-,)0(, ')() (i- (0(.
8. M(,(i *(-%) 0()() 'i*/*(8 8i( ('( -*()< %,( (0(% *i /('( ,%i0. :. P0%(* ')() '-(0i0i* 8(*( (0(% i)9,*i (i) 'i0()() 0i'(, 8 (,%,() /-i,*(() /(*i) HIV. '. A(0((0 +() ,)0(, ')() 8(i() %(- (0( (-%* 'i*, 8-*i '() 'i'i*i)9,*i ')() *(( *(0% '(-i 51$ )i0 H2O2 5< 5 < 9-* *%0i) 8-i*i 5.$$$ //@;i0-.
P-*'%- P(/-() P(*i) HIV;AIDS K0-()() 1. Bi( ',0- %0(( )0(%i ('()+( &((&(( i)- (%/%) (+- *%*/:0 HIV;AIDS /('( /(*i) '() )+(-(),() /-i,*(() ()0i HIV< *-( )%8%)i 0i V"T RS"K %)0%, 'i8-i,() ,)*i) '() '%,%)() ()&%0() /('( /(*i). 2. B(i, /(*i) *%*/:0 HIV;AIDS (%/%) HIV;AIDS< ',0- %0(( 8-i,() 0i)'(,() 'i* **%(i i)'i,(*i '() )i*i -,( 'i, *:(-( -i):i '() ),(/. 3. B(i() -,( 'i* )i*i 9-%i- (/-() ,(*%* HIV;AIDS 8-'(*(-,() :(0(0() -,( 'i* +() ('(.
P-*'%- R%&%,() 1. D)() %)i0 ,*(0() (i) 'i I)')*i( P-*0%&%() /)i-i() /)'-i0( '(/(0 (%i *%-(0 -%&%,() (0(% *(-()( 0,%)i,(*i /('( *((0 /)i-i() /)'-i0( (-%* 'i*-0(i (. D,% D,% ); );'( '(0( 0( /)' /)'-i0 i0( ( 8. D(90(D(90(- /0%)&%, /0%)&%, 0i)'(,() 0i)'(,() +() /-% /-% 'i(,%,( 'i(,%,() ) *( '(( '(( /-&(()() /-&(()() :. A(0 A(0 '() '() 8(() 8(() +() +() 'i/ 'i/-% -%,() ,() '. T)(( T)(( /)() /)()0(0(-;/ ;/)'( )'(/i /i) ) . T-()*/ T-()*/-0 -0(*i (*i +() +() 'i/ 'i/-% -%,() ,()
2. D)() %)i0 ,*(0() (i) 'i %(- )-i (. Di-,0%- -%( *(,i0;Ti HIV;AIDS /-*i(/,() *%-(0 -%&%,() '() ',%) /(*i). 8. B(i() -,( 'i* (/-,() ,(*%* i)i , D/(-0) K*(0() ')() )i*i '() )+(/(i,() 9-%i- (/-() ,(*%* AIDS. :. R,( 'i* 8-i i)9-(*i 0)0() ,('(() /)'-i0(< ,/('( /-%*((() /)-8()() ')() )i*i 9-%i- *0()'(- +() 0( 'i*'i(,().
BAB VIII METODA
1. Ti HIVAI HIVAIDS DS (,() (,() ), ),-' -'i)( i)(*i, *i,() () /(+ /(+()( ()() ) HIVAI HIVAIDS DS 'i R%( R%( S(,i0 S(,i0 "( "(+( +( K((%+()
2. S%( /(,*()(() ,i(0() /(+()() /(*i) HIVAIDS 'i R%( S(,i0 "(+( K((%+() 8-'(*(-, 8-'(*(-,() () S0()'(S0()'(- P-*'%P-*'%- O/-(*i)( O/-(*i)( @SPO +() 8-(,% 'i R%( S(,i0 "(+( "(+( K((%+() 3. P):(0 P):(0(0( (0() ) '() /(/ /(/-() -() *-0( *-0( =(%( =(%(*i *i /(+( /(+()() )() HIVAI HIVAIDS DS 'i R%( R%( S(,i0 S(,i0 "( "(+( +( K((%+() 'i(,%,() '(( -(),( /)i),(0() %0% /(+()(). 4. P(,*()( P(,*()(() () -%&%,() /(*i) /(*i) HIVAIDS HIVAIDS , R%( S(,i0 -%&%,() **%(i **%(i ')() MOU +() 'i*/(,(0i.
BAB I! PENCATATAN DAN PELAPORAN
A%- /(/-() /(+()() ('(( /(/-() +() 'i(,%,() 0i /(+()() HIVAIDS ,/( ,/('( '( &(&( &(&(-( -() ) ( ()( )(& & ) ) -%( -%( *(,i *(,i00 '() '() 'i)( 'i)(** ,* ,*( (0( 0(). ). D D) )() () 0%&%( 0%&%() ) %)0% %)0%, , )i')0i9i,(*i /(*i) HIVAIDS 'i R%( S(,i0 "(+( K((%+().
P-*'%- /):(0(0() ('(( *8((i 8-i,%0 1. K)*- )',%)0(*i,() (*i ,)*i) **%(i ')() 9-(0 +() 8-(,% 2. P0%(* (8-(0-i% )',%)0(*i,() (*i /-i,*(() R(/i' HIV;ELISA 3. P0%(* R,( M'i, 8-0()%) &((8 )+-(,() (/-() /(*i) HIVAIDS , Di)(* K*(0() P-=i)*i 4. K0%( HIVAIDS 8%(0 (/-() ,i(0() /(+()() HIVAIDS 0i(/ 8%() +() 'i0%&%,() ,/('( M()(&) M%0% ')() 08%*() Di-,0%-.
BAB ! MONITORING DAN EVALUASI
M)i0-i) '() =(%(*i /(+()() HIVAIDS 0i RS 'i(,%,() 1 /- 0(%) 1. M)(' M)('(,( (,() ) /-0 /-0%() %() 0i 0i HIV HIVAID AIDS S 2. M(,%,( M(,%,() ) *%-=+ '() =(%( =(%(*i *i 0-('(/ 0-('(/ /--( /--( +() 0( 0( 'i(,*()(, 'i(,*()(,() () 3. M8%(0 M8%(0 /(/-() /(/-() 0)0() 0)0() /(,*()(( /(,*()(() ) )i0-i) )i0-i) =(%(*i =(%(*i /(+()() /(+()() HIVAIDS HIVAIDS
4. M(/-,( M(/-,() ) (*i )i0-i) )i0-i) '() =(%(*i =(%(*i /(+( /(+()() )() ,/('( ,/('( Di-,0%Di-,0%- R%( S(,i0 S(,i0 "(+( K((%+().
BAB !I PENUTUP
Ti)i)+( 0i),(0 /)+8(-() HIV '() AIDS /('( ,/, ()(/%) 8-(-0i 8(( *( *(,i ,i) ) 8()+ 8()+(, (, -() -() )& )&(' ('ii *(,i *(,i0< 0< '() '() 8 8%0% %0%, ,() () &(*( &(*( /( /(+( +()( )() ) ,* ,*( (0( 0(). ). P-,8()() /)+(,i0 +() (8() '(-i i)9,*i HIV 8-(-0i 8(( /(*i) *'i,i0 'i *'i,i0 )&(' )&('ii 8i 8i *(,i0 *(,i0 '(( '(( &() &(),( ,( (,0% (,0% +() +() /()&() /()&()< < 8%0 8%0%, %,() () *(,i *(,i) ) 8()+( 8()+(, , /-((0() ,*(0(). (,0% '() *%8- '(+( +() 'i8-i,() %)0%, -((0 /(*i) HIV '() AIDS *'i,i0 'i *'i,i0 '(/(0 )(8i*,() *%8- '(+( %)0%, (,0i=i0(* ,*(0() (i))+(.
Bi( Bi( %/(+( %/(+( /)() /)()% %() ()() () 0i'(, 0i'(, 'i0i) 'i0i),( ,(0,( 0,() ) (,( (,( (,() (,() )+8 )+8(8, (8,() () //-(* (*(( ((() () ,*(0() )(*i)(. Di(-(/,() ')() ('()+( /'() /(+()() HIVAIDS '(/(0 8()0% R%( S(,i0 S(,i0 "(+( "(+( K((%+() K((%+() 8-/-() *-0( '(( '(( /--( /--( )(*i)( )(*i)( /)()% /)()%()() ()() HIVAIDS ,%*%*)+( 'i B()'%) B(-(0.
